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Abstract 
Improvements in military trauma care during the wars in Afghanistan and Iraq have contributed to 
increased survival rates for combat-injured American military personnel. Yet, little is understood about the 
short- and long-term physical and mental health symptoms resulting from these injuries. Understanding 
clinical presentations and symptom trajectories in survivors of complex combat injuries is paramount to 
the future development and implementation of interventions that are capable of reducing the disabling 
effects of symptoms and, subsequently, improving health outcomes across the continuum of trauma 
care. This dissertation addresses the key question: in an era of unprecedented survival after complex and 
life-threatening injuries, what are the short- and long-term symptom trajectories of post-traumatic stress 
disorder (PTSD) and pain, even after exposure to pain management interventions, specifically regional 
anesthesia (RA)? Furthermore, this investigation evaluates the effectiveness of RA on reducing pain 
intensity after injury. To address these inquiries, this dissertation used the longitudinal data from one of 
the largest and most comprehensive datasets of patient-reported outcomes from American military 
personnel and veterans wounded in action during Operation Enduring Freedom and Operation Iraqi 
Freedom. Principle findings were: 1) There is an established association between pain and mental health 
symptom presentations in combat-injured military personnel and veteran populations that exists 
throughout care settings where nurses are practicing; 2) PTSD symptom severity, and pain intensity and 
interference are significantly correlated up to twenty-one months after injury; 3) Worsening PTSD 
symptom trajectories are associated with higher pain intensity after injury compared to improving or 
stable PTSD symptom trajectories; 4) Early receipt of RA for pain management following combat injury is 
associated with improved patient-reported pain outcomes; 5) Markov chains are a practical method for 
characterizing probabilistic pain trajectories after combat injury, and can be beneficial in future work to 
examine the benefits of analgesic interventions. Results inform future directions for advancing nursing 
science research and directing practice, in the context of implementing interventions to manage pain 
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Rosemary C. Polomano, PhD, RN, FAAN  
Improvements in military trauma care during the wars in Afghanistan and Iraq have 
contributed to increased survival rates for combat-injured American military personnel. 
Yet, little is understood about the short- and long-term physical and mental health 
symptoms resulting from these injuries. Understanding clinical presentations and 
symptom trajectories in survivors of complex combat injuries is paramount to the future 
development and implementation of interventions that are capable of reducing the 
disabling effects of symptoms and, subsequently, improving health outcomes across the 
continuum of trauma care. This dissertation addresses the key question: in an era of 
unprecedented survival after complex and life-threatening injuries, what are the short- 
and long-term symptom trajectories of post-traumatic stress disorder (PTSD) and pain, 
even after exposure to pain management interventions, specifically regional anesthesia 
(RA)? Furthermore, this investigation evaluates the effectiveness of RA on reducing pain 
intensity after injury. To address these inquiries, this dissertation used the longitudinal 
data from one of the largest and most comprehensive datasets of patient-reported 
outcomes from American military personnel and veterans wounded in action during 
Operation Enduring Freedom and Operation Iraqi Freedom. Principle findings were: 1) 
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There is an established association between pain and mental health symptom 
presentations in combat-injured military personnel and veteran populations that exists 
throughout care settings where nurses are practicing; 2) PTSD symptom severity, and 
pain intensity and interference are significantly correlated up to twenty-one months after 
injury; 3) Worsening PTSD symptom trajectories are associated with higher pain 
intensity after injury compared to improving or stable PTSD symptom trajectories; 4) 
Early receipt of RA for pain management following combat injury is associated with 
improved patient-reported pain outcomes; 5) Markov chains are a practical method for 
characterizing probabilistic pain trajectories after combat injury, and can be beneficial in 
future work to examine the benefits of analgesic interventions. Results inform future 
directions for advancing nursing science research and directing practice, in the context of 
implementing interventions to manage pain after serious injury in order to maximize 
recovery across military, veteran, and civilian populations.  
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Since the terrorist attacks on September 11, 2001 in the United States (U.S.), over 2.5 
million American service members deployed to engage in counterterrorism efforts 
globally.1 Service members operating on the front-lines of combat zones encounter 
modern warfare weaponry, including high intensity weapons and improvised explosive 
devices (IED) that have the potential to inflict unprecedented injury patterns and 
severity.2,3 During the past 17 years of these global conflicts, more than 50,000 service 
members have been wounded in action.4 Many of these service members have sustained a 
multitude of injuries across several organ systems and anatomical regions of the body, 
known as polytrauma.5 For the first time in U.S. warfare history, the majority of these 
combat wounds are survivable despite their magnitude and severity, largely due to 
advancements in military trauma care.6 This survivability means individuals are living 
with serious injuries that were previously considered fatal. Therefore, changes are needed 
in the management of both acute and chronic injury-related pain. Moreover, little is 
understood about the long-term physical and mental health symptom trajectories among 
survivors of polytrauma. 
Progress in combat casualty care extends to military hospital care and comprehensive 
rehabilitative service where the toll of warfare is evident in both the visible and invisible 
wounds of war. Chronic pain and post-traumatic stress disorder (PTSD) are frequently 
observed together among veterans returning from Operation Enduring Freedom (OEF) 
and Operation Iraqi Freedom (OIF).7,8 Estimates show 30% to 68% of injured OEF/OIF 
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veterans experience symptoms of PTSD, and over 80% report experiencing chronic 
pain.9-11 Chronic pain is associated with PTSD, functional impairment, behavioral health 
issues, and compromised health-related quality of life.12-14 Combat-injured military 
personnel report worse pain and more severe mental and physical health symptoms than 
noncombat injured personnel exposed to similar wartime stressors.15-18 Veterans with 
comorbid symptoms have increased care utilization and almost double the costs of care 
within the Veterans Health Administration (VHA), a division of the U.S. Department of 
Veterans Affairs (VA), than those with chronic pain or PTSD alone.19  
Early pain interventions in the combat theater, during transportation, and throughout 
acute care hospitalization improve pain outcomes20-24 and potentially reduce the risk of 
developing mental health illnesses after combat injury.25,26 Traumatic tissue damage 
inflicted by combat injuries, triggers an extensive inflammatory reaction consisting of the 
release of neurotransmitters to elicit an intracellular and neuropsychological response.27 
When undermanaged, this persistent inflammatory response can lead to chronic pain. The 
initial management of acute pain may benefit injured persons by interrupting this cascade 
of neurotransmitters.28 This interruption may mitigate the development of chronic pain 
and thereby limit the interactions between pain intensity and PTSD symptom severity that 
can contribute to disability.29 Comprehensive pain management, delivered as close as 
possible to the time of injury, is essential for all seriously injured persons. Despite robust 
research in the field of analgesics used after combat injury for improving pain 
management, the mechanisms of optimal delivery of anesthesia and analgesia after 
serious injury remains under researched.30,31 Since most who sustain serious injuries will 
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survive, it is critical to ensure that injured service members have every opportunity to 
return home with minimal pain. 
Purpose and Outline of the Research 
This chapter is a brief overview of the dissertation and contextualizes this research. The 
purpose of this work is to identify the complex interrelatedness of pain and mental health 
conditions, such as PTSD, and the reciprocal influence symptoms have after combat 
injury. Additionally, this work evaluates the effects of early pain management after 
combat related-injury on pain intensity and interference. The chapter provides a brief 
summary and rationale of terms used throughout the dissertation. The intervention of 
interest, regional anesthesia (RA), is introduced and its utility in addressing the pain 
management challenges of combat-injured persons is discussed. An overview of the aims 
of each chapter follows before considering the significance of this work.  
Subsequent chapters include the three component papers that comprise this 
dissertation. Initially, an integrative review of the extant literature was undertaken in 
order to identify clinical presentations and relationships between PTSD, depression, and 
pain after injury among OEF/OIF military personnel and veterans (Chapter 2). The 
remaining chapters detail a secondary analysis of the longitudinal data from the Regional 
Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) (Chapters 3 and 4). 
Finally, the dissertation concludes with a discussion on leveraging the findings of this 
symptom science research to inform future pain management approaches in order to 
improve short- and long-term health outcomes after serious injury (Chapter 5).  
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RAMBPOS is a prospective longitudinal cohort study investigating the effects of 
early aggressive RA following major combat-related limb injuries on subsequent pain, 
functional status, behavioral health, and health related quality of life outcomes.32 
Individuals received RA either in a combat support hospital, during evacuation 
transportation, upon arrival to a U.S. military medical facility, intraoperatively, or 
throughout acute care. Individuals not receiving RA within two months of injury received 
conventional systemic pain management. Military personnel hospitalized with at least 
one major limb combat-related injury between 2007 and 2014 were eligible for 
enrollment during acute care or inpatient physical rehabilitation at one of two domestic 
U.S. military treatment facilities. Participants were excluded if they sustained major head 
trauma with cognitive deficits, defined as moderate or severe traumatic brain injury 
(TBI), had an inability to concentrate, clinician observed poor judgment and impulse 
control, substantial hearing loss, and individuals with bilateral upper extremity 
amputation with no alternate means to complete survey forms. Exclusion criteria were 
implemented due to potential cognitive inability to provide patient-reported outcomes. 
The final sample of 386 combat-injured participants provided sociodemographic, 
pain, behavioral health, and injury data. After being screened and enrolled during acute 
care or rehabilitation, participants could join RAMBPOS anytime within two years after 
injury. Over the telephone, patient-reported outcomes were collected monthly in the first 
six months after injury and every three months thereafter, up to two years post-injury 
(See study schema in Figure 1-1). Retrospective abstraction of injury and clinical care 
data from health records during the initial hospitalization at military facilities were 
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integrated into the dataset, including pertinent injury information, receipt of early RA, 
and other multimodal pain therapies. The study was an interdisciplinary partnership 
between providers and researchers at Walter Reed National Military Medical Center, 
Brooke Army Medical Center, Veterans Affairs Office of Research and Development, 
Defense & Veterans Center for Integrative Pain Management, and the University of 
Pennsylvania.  
Definition of Terms 
Polytrauma 
Due to the proliferation of high velocity weapons and IEDs employed in modern warfare, 
it is important to examine the complex injury patterns and mechanisms sustained by U.S. 
military personnel in Iraq and Afghanistan. Polytrauma is defined as injuries to multiple 
organ systems and anatomical regions of the body, most often due to blast exposure. 
Polytrauma comprises internal bleeding, major extremity injuries, TBIs, and other 
neurological injuries.5 Nearly three quarters of all combat casualties in OEF/OIF are the 
result of explosive mechanisms.3 These intense explosive reactions catalyze a pressurized 
blast wave that cause compression and shearing of tissue, damage to gas-filled organs 
(e.g. lungs), and TBI. Subsequent injuries after a blast, include blunt or penetrating 
injuries as materials from within a bomb casing and environmental debris are carried with 
the explosion.33 All participants in RAMBPOS experienced at least one major limb injury 
and sustained a mild TBI (mTBI) given the mechanisms of their injuries. For the purpose 





Pain is an expected response to severe injury. Pain is defined as “the unpleasant sensory 
and emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage”.35 The tissue damage induced by severe physical trauma 
initiates an inflammatory response of neurotransmitters that heightens both peripheral and 
central nervous system sensitization. Prolonged activation of this inflammatory response 
and nociception can cause a reduction in pain thresholds, allodynia, and an increased 
reaction to noxious stimuli, hyperalgesia.36 These processes ultimately lead to 
maladaptive neuroplasticity, the remodeling of neuronal structures that can contribute to 
the transition from acute pain response to chronic pain.27 Chronic pain is pain that 
persists beyond the expected time of healing; three months is the most often used point of 
division between acute and chronic pain.35 About 60% of severely injured civilians 
experience injury-related pain a year after trauma care.37 In comparison, over 80% of 
combat-injured veterans report experiencing chronic pain between 6 to 8 months after 
injury.10,12  
Pain is a multidimensional phenomenon, requiring several levels of measurement in 
order to accurately capture an individual’s painful experience.29,38 Subjective pain 
intensity is a common measure in clinical practice and research. Pain intensity is defined 
as the severity to which pain is experienced. Common assessments of pain intensity 
include numeric rating scales where zero (0) refers to no pain, and ten (10) is the greatest 
severity, or most intense, pain can be experienced. However, pain is an inherently 
subjective experience and individuals interpret measurement scales differently. As such, 
7 
 
it is imperative pain intensity be evaluated beyond just what a research participant or 
patient is currently experiencing at time of assessment.39 Measuring different components 
of pain, such as worst pain or least pain experienced in the past 24 hours, can provide 
valuable insight between assessment points in prospective research. Measuring the 
multiple dimensions of pain, such as worst, least, and current pain, is important to 
capturing patient’s total pain experience. Pain interference is defined as the impact of 
pain on daily living and functioning.40,41 The extent of pain interference refers to how 
pain hinders a person’s engagement with social, cognitive, emotional, physical, and 
recreational activities. When measured and discussed together, in this research, pain 
intensity and interference are referred to as patient-reported pain outcomes, or simply 
pain outcomes. 
Post-traumatic Stress Disorder (PTSD) 
PTSD is a mental health condition that can develop after experiencing a traumatic and/or 
dangerous event, such as combat injury. Physical trauma can cause a dysregulation of 
multiple biological stress-mediating systems.42 While individuals’ responses to trauma 
differ, it is common to experience symptoms of post-traumatic stress (PTS). To be 
diagnosed with PTSD, an individual needs to present with one re-experiencing symptom 
(e.g. nightmares, flashbacks), three avoidance symptoms (e.g. loss of interest, amnesia, 
social detachment), and two hyperarousal or reactivity-related symptoms (e.g. difficulty 
sleeping, hypervigilance) out of 17 qualifying PTS symptoms for at least one month that 
impairs an area of their functioning, according to the American Psychiatric Association’s 
4th edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV).43 
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Not all combat-injured individuals will develop PTSD. On average, 11% to 20% of 
OIF/OEF veterans have a PTSD diagnosis in a given year;44 with a higher proportion, 
between 30% to 68%, observed in combat-injured veterans.9,12,14 For the purpose of this 
dissertation the term PTSD (DSM-IV criteria) will be used throughout when referring to 
both PTSD and PTS. The Diagnostic and Statistical Manual for Mental Disorders, Fifth 
Edition (DSM-5) was published after RAMBPOS screening and enrollment was 
completed. Therefore, the DSM-IV criteria for PTSD were utilized to ensure continuity 
throughout the study period across participants.  
Symptom Trajectories 
Symptom trajectories, as defined in this dissertation, are changes in a disease’s or a 
condition’s clinical presentation over time. Evaluating symptom trajectories is essential 
to identifying interceding points when effective interventions, capable of altering the 
course of symptoms, can be used in clinical practice. Moreover, investigations of disease 
specific symptom trajectories can enable the identification of pathways that change the 
severity of co-occurring symptoms, or symptom clusters, and inform best strategies for 
managing conditions simultaneously. Due to the frequent co-presentation of both pain 
and PTSD in veterans (50% to 80% of veterans diagnosed with PTSD report 
experiencing chronic pain),9,12,46 it is of value to consider the potential influence 
symptom trajectories have on one another.  
Pain after injury is dynamic and requires longitudinal assessment by clinicians and 
researchers. Pain trajectories offer valuable insight into understanding clinical 
presentations of pain after combat injury.47 Current evaluations of post-combat injury 
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pain are predominantly cross-sectional21,24,48 and divided between understanding acute 
pain or chronic pain presentations.18,22,26 Previous investigations on acute postoperative 
pain demonstrate the utility in capturing pain trajectories.47,49 For example, there is mixed 
evidence to support that acute pain trajectories, specifically individuals with high pain 
intensity, can predict the development of post-surgical chronic pain several months 
later.50 There is a value to understanding acute pain trajectories given that they provide 
greater information of change in pain intensity over time than conventional intermittent 
assessments, while also improving measurement precision.47,49,51 Since pain intensity is 
subjective, it is necessary to assess intra-individual fluctuations in response to acute pain 
interventions and chronic pain prevention strategies.52 Considering pain trajectories are 
dynamic in nature, simple linear modeling may be inadequate to other statistical 
approaches, such as mixed effects modeling47 or probabilistic Markov modeling.53 
Markov modeling has been demonstrated to be a feasible method for simulating disease 
processes, including postoperative pain trajectories,53 but has yet to be applied in 
characterizing post-combat injury pain trajectories. Markov modeling allows for the 
creation of pain states, defined as a quantified measure of pain intensity at a discrete time 
point in recovery after injury. The transition from one pain state to another (i.e. 
fluctuations in pain intensity) over time, can be considered a trajectory.  
PTSD symptoms also have a variable course after traumatic events that can be acute 
or chronic, with symptoms fluctuating, remitting, or even worsening.44,54 Therefore, 
capturing PTSD symptom trajectories after injury are of vital importance in order to 
inform care throughout recovery. The majority of studies following trauma exposed 
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persons, often do not exceed one year of evaluation and do not include more than two 
assessment points.55 However, a few of the longitudinal investigations that do exist 
highlight the diverse presentations of PTSD symptom trajectories, and that subsyndromal 
levels of PTSD can contribute to disability and inhibit recovery.56 This sub-threshold 
PTSD symptom severity is the most common trajectory seen in OEF/OIF military 
personnel and veterans.57 However, more research is required to examine distal health 
outcomes predicted by PTSD symptom trajectories.58 
Regional Anesthesia (RA) 
Early pain management interventions, including RA, are paramount in the immediate 
post-traumatic injury period and throughout acute care hospitalization. RA is an effective 
and efficient intervention to manage acute pain and improve pain outcomes.24,48,59-61 
When used as part of a multimodal regimen, RA can target discrete components of the 
peripheral and central pain pathways to provide effective analgesia at lower opioid dosing 
and producing fewer adverse effects than standard systemic anesthesia and analgesic 
approaches.62 Multimodal analgesia refers to the combination of analgesic drugs from 
different classes that have a synergistic effect and can maximize reductions in pain 
intensity at lower doses and reduced dependence on opioids.62 RA delivered in 
RAMBPOS includes the use of neuraxial anesthesia, the local administration of an 
anesthetic into the spinal cord’s epidural or intrathecal space, as well as peripheral nerve 
blocks, directed towards an isolated nerve or plexus through the injection of a local 
anesthetic under ultrasound guidance. These RA techniques allow for a high precision 
delivery of analgesia to injured areas of the body to augment multimodal regimens.  
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The austere environment, combined with the complex care associated with combat 
trauma, necessitates the use of agile and effective pain management interventions. For 
example, systemic pain therapies come with challenges, including timeliness of 
administration and therapeutic effect.62 General anesthesia requires advanced logistics, 
such as availability of a dependable source of electricity and compressed gas that are not 
always available in the battlefield. Use of RA, is hypothesized to reduce complications in 
civilian surgical patients.62-65  Improved outcomes with RA, over systemic approaches, 
include the avoidance of intubation and mechanical ventilation, minimal risk of 
respiratory and circulatory depression, and improved postoperative analgesia.31,65 After 
being introduced in the Vietnam War, RA is now commonly used to manage pain 
following injuries in both Iraq and Afghanistan. In military and the civilian populations 
RA has proven benefits of optimal acute pain severity control with fewer side effects, 
minimal or non-opiate therapy, and improved functional recovery.26,31,59,65-67 A meta-
analysis comparing RA to conventional analgesia (e.g. intermittent opioids) found RA to 
be effective in preventing persistent postoperative pain, a type of chronic pain, in civilian 
populations up to one year after surgery.68 Yet, this analysis did not include studies with 
combat-injured OEF/OIF military personnel, and results were weakened due to both 
small samples and the limited availability of data beyond one year. A cross-sectional 
study of OEF/OIF amputees identified individuals who received pain management 
through RA had over 50% lower odds of developing subtypes of chronic pain, than 
amputees not receiving RA.69 
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Chapter Aims and Rationale 
The following chapter aims were designed to achieve the goals this dissertation, which 
were to identify the complex interrelatedness of pain and mental health, and the effects of 
RA on patient-reported outcomes after combat related-injury.  
Chapter 2  
Aim: This integrative review synthesized clinical presentations and interrelationships 
among characteristics and mechanisms of combat injury, PTSD, depression and pain in 
American military service members and veterans serving in OEF/OIF wars. This paper 
provides an evidence table of clinical presentations of these often co-occurring conditions 
and injury characteristics that helps to contextualize the RAMBPOS participants. The 
results of this review are foundational to understanding combat trauma for the data-based 
papers that follow.  
Rationale: The interrelationships and presentations identified in this review of the 
literature establish a clinical knowledge base for this dissertation and future lines of 
inquiry in the field of combat injury science. This essential review of the literature is one 
of the first to examine the polytrauma phenomenon from the nursing science perspective.  
Chapter 3  
Aim: Evaluate the association of RA and PTSD symptom trajectories, on pain intensity 
and interference over the first two years after injury.  
Hypothesis: There will be a positive moderate correlation between pain intensity and 
interference, and PTSD symptom severity using repeated patient-reported outcome 
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measures. Pain intensity and interference point estimates will differ based on RA receipt 
status, and on PTSD symptom trajectories throughout the course of RAMBPOS.  
Rationale: This analysis of the RAMBPOS cohort is critical to understanding the effects 
of PTSD symptom trajectories on pain following combat injury. Moreover, it is 
imperative to utilize the possible relationship between PTSD trajectories and pain 
outcomes as support for the value of integrating simultaneous care of either condition 
across rehabilitation and recovery. 
Chapter 4  
Aim: Characterize probabilistic pain trajectories, stratified by those who did or did not 
receive RA, after combat injury across multiple dimensions of pain intensity. 
Hypothesis: Using a Markov model approach to examine pain trajectories, will illustrate 
that participants receiving RA are less likely to transition to and less likely to remain in a 
high pain intensity state over the two year model period compared to those not receiving 
RA. 
Rationale: By using patient-reported pain outcome measures to characterize pain 
trajectories, it is possible to capture the multidimensional nature of pain after combat 
injury while accounting for both time and pain management interventions. The 
construction of probabilistic pain trajectories using transition matrices, stratified by RA 
recipients, goes beyond simple linear numeric scales assessing temporal cross-sectional 




With the parent study’s data, this dissertation is an opportunity to understand the 
association of pain and PTSD after injury, and consider the long-term benefits of 
receiving early pain management through RA. The original aims of this dissertation are 
unique from that of RAMBPOS, which only examined pain outcomes between 
individuals who did or did not receive RA and did not consider mental health outcomes 
or symptom trajectories. The aims of this dissertation and research protocol received 
institutional review board (IRB) exempt status by the VA Medical Center Research & 
Development Committee (Protocol #01685) and the University of Pennsylvania (Protocol 
#827892).  
This program of research is guided by The Biopsychosocial Model of Chronic Pain 
(Figure 1-2).71 This model assumes the causes of, and health outcomes from, chronic 
pain are affected by a magnitude of diverse social, physical, pathological, environmental, 
and psychological factors in an individual’s life. Therefore, in order to adequately 
manage chronic pain, all of these factors must be addressed by providers and caregivers 
to the fullest extent possible. In this research, the model is used to place an injured 
individual’s perception and response to pain in the context of the interrelationships 
between biological changes from tissue trauma and psychological health, such as 
PTSD.72 There is a shared pathophysiology between comorbid chronic pain and PTSD 
that can be amplified when dysregulation in the peripheral processes (i.e. immune, 
autonomic, endocrine) occurs in response to tissue trauma.73 Stress stimulated from 
traumatic events, such as injury, increases dysregulation in the periphery processes that 
heighten afferent feedback to the central processes in the model. For example, PTSD 
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associated neurotransmitters released from the inflammatory immune response go on to 
potentially influence pain transmission and amplification along these pathways. 
Behavioral reactions that result from changes in the central cognitive processes may 
influence PTSD symptom presentations, alter patient-reported pain interference, and 
exacerbate emotional responses. Pain driven emotions, such as feelings of vulnerability 
or anger, that are also associated with PTSD interact and alter cognitive appraisals of 
pain. Cognitions, in turn, attach meaning to the emotional experience and may activate 
emotional responses and amplify the pain experience, propagating a cycle of nociception, 
distress, and disability due to comorbid pain and PTSD.71,72,74 The social aspects of a 
combat-injured individual’s life interact with both the physiological and psychological 
aspects of injury to further modulate symptom severity. The severity of symptoms can 
then perpetuate an injured-person’s ability to meet social and interpersonal relationship 
expectations, independently complete activities of daily living, and navigate their 
environment effectively. By adapting Engel’s generic biopsychosocial model of 
disease,75 pain scientists have used the Biopsychosocial Model of Chronic Pain to 
identify that: 
“Research supports a strong bidirectional link between mood disorders and persistent 
pain; the development of an enduring pain condition confers a substantially increased 
risk for the subsequent diagnosis of an affective disorder, and psychosocial variables 
such as depression, anxiety, and distress are among the most potent and robust 
predictors of the transition from acute to chronic pain…efficacious analgesic 
treatments that reduce the frequency and intensity of pain should have a beneficial 
effect on patients’ affective states and appropriate treatment of emotional distress 
should have a positive influence on the experience of pain.”76  
However, in order to understand the development, co-occurrence, and contiunuation of 
PTSD symptoms and pain requires this area of research to move beyond cross-sectional 
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descriptions of symptoms after injury. Further, research examining both conditions must 
consider the effects of analgesic treatments, which can influence various aspects of the 
biopsychosocial model in the efferent and afferent feedback between peripheral and 
central processes. To do so requires the assessment of larger datasets measuring these 
interrelated conditions, in order to further illuminate their interactions on one another. For 
this reason, components of this dissertation consider how PTSD trajectories influence 
pain intensity and interference, while also evaluating the effects of RA, which in turn 
may improve acute pain and potentially influence the development of future chronic pain.  
Significance 
The ability to expand science in the use of early acute pain management with RA and 
demonstrate its association with long-term health outcomes will be invaluable for future 
trauma responders and clinicians managing acute pain after injury. The delivery of RA 
after injury requires a coordinated effort among emergency responders, surgeons, nurses, 
and trained anesthesia providers, such as Certified Registered Nurse Anesthetists 
(CRNA).20,62 CRNAs are present in military, veteran, and civilian healthcare settings, and 
therefore it is critical that CRNAs are trained to deliver effective pain management and 
trauma care to the fullest extent of their scope of education and practice.77 Additionally, 
timely and effective pain management is paramount to civilian, military, and veteran 
populations. Studying short- and long-term benefits of early RA for combat trauma in this 
dissertation has the potential to strengthen injury science and provide foundational 
support to implementing CRNA led interventions after injury.  
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Understanding the short- and long-term health outcomes following serious injury is a 
priority to both military and civilian agencies. This dissertation directly supports the 
missions of many national organizations and their commitments to meeting the health 
needs of the nation’s injured service members and civilians. The objectives of this 
dissertation are well positioned with the National Institute of Nursing Research’s (NINR) 
Strategic Plan to better manage symptoms of acute and chronic illnesses such as pain.78 
NINR’s longstanding commitment to recognizing that pain can be a debilitating symptom 
and chronic condition, furthers the significance in developing and testing effective CRNA 
led pain management interventions, like RA. Similarly, the 2011 Institute of Medicine, 
now known as the National Academy of Medicine, report called for a cultural 
transformation in pain prevention, care, and research to be guided by the National 
Institutes of Health led National Pain Strategy.79 The National Pain Strategy seeks to 
promote research that benefits citizens most at risk of developing chronic pain and 
promote the implementation of non-opiate interventions.80 The use of comprehensive 
multimodal analgesics delivered via RA offers a low dosing, or opioid-sparing, 
alternative for managing pain after serious injury. Research evaluating the effects of RA, 
such as this dissertation, aligns with the 2016 Centers for Disease Control and Prevention 
Guideline for Prescribing Opioids for Chronic Pain’s call for researchers to evaluate the 
effectiveness of alternative non-opiate treatment options for pain.81 The findings of this 
dissertation will further the knowledge needed to leverage advances in RA techniques in 
order to promote best pain management practices, as put forth by the Army Surgeon 
General’s 2010 Pain Management Task Force.82  
18 
 
The health needs of combat injury survivors continue long after acute care, and 
therefore healthcare providers must anticipate and evaluate changes in symptoms. 
Findings from this dissertation emphasize that continued evaluation by clinicians and 
researchers is required in this population, based on the complex presentations between 
pain, PTSD, and depression after combat-related injury (Chapter 2). This dissertation 
evaluates the long-term effects of RA, and the reciprocal influence of PTSD total 
symptom severity trajectories, on patient-reported pain outcomes up to two years after 
injury (Chapter 3). Moreover, innovative methodologies can be utilized to identify which 
acute care interventions are most likely to be successful in changing the trajectory of 
acute to chronic illnesses, and how interventions can influence the dynamics of pain 
presentations (Chapter 4). Findings from this dissertation have the potential to inform 
future trauma care planning, beginning from the time of acute care, in order to optimize 
the health of traumatically injured persons throughout rehabilitation and recovery.  
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Figure 1-1 Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) Schema 
 
 
BPI = Brief Pain Inventory; NPS = Neuropathic Pain Scale; PCL = PTSD Checklist; TOPS = Treatment Outcomes in Pain Survey; SF-12 = 12-item Short Form 
Survey.  



























































Figure 1-2 The Biopsychosocial Model for Chronic Pain 
 
  
A conceptual model of the psychosocial interactive processes involved in 
health and illness.  
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Complexity of the Relationships of Pain, Posttraumatic Stress, and Depression in 





Understanding the complex interrelationships between combat injuries, physical 
health, and mental health symptoms is critical to addressing the healthcare needs of 
wounded military personnel and veterans. The relationship between injury characteristics, 
pain, posttraumatic stress disorder (PTSD), and depression among combat-injured 
military personnel is unique to modern conflicts and understudied in the nursing 
literature. 
Aim 
This integrative review synthesizes clinical presentations and relationships of 
combat injury, PTSD, depression, and pain in Operation Enduring Freedom (OEF) and 
Operation Iraqi Freedom (OIF) United States military service members and veterans. 
Methods 
A literature search was conducted using relative key terms across databases to 
identify peer-reviewed publications between 2001 and 2016 that examined health 
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outcomes of combat-injured persons in OEF and OIF. The quality of evidence was 
evaluated and results synthesized to examine the association of combat injury as a risk 
factor for PTSD, the relationship of PTSD and depression pre- and postinjury, and pain 
management throughout care. 
Results 
Twenty-two articles were included in this review. Greater injury and pain severity 
poses risks for developing PTSD following combat injury, while early symptom 
management lessens risks for PTSD. Depression appears to be both a contributing risk 
factor to postinjury PTSD, as well as a comorbidity. 
Linking Evidence to Action 
Findings demonstrate a compelling need for improvements in standardized 
assessment of pain and mental health symptoms across transitions in care. This 
integrative review informs nurse researchers and providers of the clinical characteristics 
of pain, PTSD, and depression following combat injury and offers implications for future 






Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) led to the 
deployment of millions of United States military personnel. Over 50,000 troops serving 
in OEF and OIF experienced combat injuries (Defense Casualty Analysis System, 2017). 
Mechanisms of battlefield trauma have shifted to high-velocity weapons and improvised 
explosive devices, capable of inflicting devastating injuries. Polytrauma describes 
injuries to multiple organ systems and anatomical regions of the body, often due to blast 
exposure. Polytrauma includes internal bleeding, major extremity injuries, traumatic 
brain injuries (TBI), and other neurological injuries (United States Department of 
Veterans Affairs, 2015). Advancements in military trauma care and evacuation 
capabilities to higher levels of care have led to unprecedented increases in survival rates 
and subsequently new patterns of complex healthcare needs of polytrauma survivors 
(Clifford et al., 2014). 
The polytrauma clinical triad, defined by pain, posttraumatic stress disorder (PTSD), 
and TBI, is evident in over 40% of polytrauma OEF and OIF military service members 
and veterans (Lew et al., 2009). High rates of mental disorders, such as depression, 
coexist with this polytrauma clinical triad, further complicating the polytrauma 
rehabilitative services required to address biopsychosocial healthcare needs postinjury 
(Vyas et al., 2016). The concerning prevalence of depression seen in combat exposed 
uninjured veterans (28%), compared to other mental health conditions, emphasizes the 
importance of examining the interrelatedness of depression, PTSD, and pain after combat 




of depressive symptoms, for all veterans, seeking care in primary care settings is an 
effective suicide prevention approach (Denneson, Williams, Kaplan, McFarland, & 
Dobscha, 2016). 
This integrative review summarizes and analyzes the state-of-the-science pertaining to 
the complex relationships of pain, PTSD, and depression experienced by combat-injured 
OEF and OIF military service members and veterans. Because pain, PTSD, and 
depression are present in the U.S. civilian trauma population, research from combat-
injured military service members and veterans can inform civilian trauma care (National 
Academies of Sciences, Engineering, and Medicine, 2016). Although TBI is part of the 
polytrauma triad, this review only focuses on research addressing pain and mental health 
outcomes associated with combat injuries, independent of neurological conditions. The 
polytrauma literature continues to expand, however, there is still a paucity of studies 
examining the interrelatedness of pain, PTSD, and depression associated with combat 
injury. The purpose of this review is to evaluate and synthesize current research on the 
influence of clinical injury characteristics related to the onset and persistence of pain, 




A targeted search of available literature, published between September 2001 and 
December 2016, was conducted in PubMed, CINAHL, Scopus, and EMBASE, using the 




adult (PubMed defines as >19 years); military personnel; veterans; veterans’ health; U.S. 
Department of Veterans Affairs; Veterans Hospitals; wounds, injuries; penetrating 
wounds; gunshot wounds; multiple trauma; pain; PTSD; and depression (Figure 2-1). 
Combat injury refers to a sustained injury incurred in the line of duty because of armed 
conflict (United States Department of Veterans Affairs, 2015). Search terms are available 
online with this article. 
Data Extraction 
Studies retained for analysis met the following criteria: (a) samples included U.S. 
military personnel or veterans who sustained combat injuries in the OEF and OIF wars; 
(b) pain, PTSD, and depression were primary or secondary outcomes; (c) investigations 
conducted in combat theater, military or Veterans Health Administration (VHA) 
healthcare facilities; and, (d) secondary analyses of Department of Defense (DoD) or 
VHA databases. Citations excluded were: (a) case studies, commentaries, expert 
consensus reports, and editorials; (b) investigations of military or veteran populations 
with TBI as a primary variable of interest; (c) studies not investigating combat-related 
physical trauma or an outcome of interest (e.g., pain, PTSD, depression); (d) publications 
prior to September 11, 2001; (e) non-English publications; and (f) investigations of 
biomarkers, genomics, or imaging. Of the 1,848 database citations, 1,778 abstracts met 
the criteria for inclusion, and 286 full text publications were evaluated applying exclusion 





Studies were evaluated for methodological quality, informational value, and 
representativeness of combat-injured military personnel and veterans (Whittemore & 
Knafl, 2005). The strength of evidence of each study was evaluated using Melnyk and 
Fineout-Overholt's (2011) “Rating System for the Hierarchy of Evidence” (Level 1—
highest to Level 7—lowest). The strongest evidence to base clinical practice on is rated 
Level 1 and includes both systematic reviews and meta-analyses of randomized 
controlled trials. Level 2 refers to well-designed randomized control trials, whereas Level 
3 evidence comes from controlled trials without randomization. Level 4 contains cohort 
and case-control research studies. Level 5 evidence refers to systematic reviews of 
descriptive and qualitative studies. Level 6 includes single descriptive studies and 
qualitative work, and Level 7 refers to expert opinions. The integrative review process 
included an analysis of samples across studies, data reduction, data display, data 
comparison, conclusion drawing, and verification throughout the Results section, with 
key findings synthesized and evidence rated in Table 2-1 (Whittemore & Knafl, 2005). 
Results 
The 22 studies included in this review were published in peer-reviewed journals and 
comprised 10 retrospective analyses, four prospective observational studies, four 
retrospective cohort studies, two cross-sectional descriptive studies, one descriptive 




Samples, Data Sources, and Settings 
Samples ranged from 50 to 191,747 participants in size, and were predominately 
young (22–31 years, average age), Caucasian (46–95% of samples), and almost entirely 
male (72–100% of samples). Sample data sources for retrospective studies were obtained 
from the Combat Trauma Registry Expeditionary Medical Encounter Database and the 
Joint Theater Trauma Registry, subsequently renamed DoD Trauma Registry, and 
National VHA health records. Other studies were conducted at, or using data from, 
military facilities (e.g., domestic and overseas, including a combat support hospital) and 
within the VHA system. Variations in study settings and data sources, from time of 
combat injury to rehabilitative care, provide a broad range of results capturing clinical 
presentations postinjury. 
Combat Injury: Risk Factor for PTSD 
The incidence of PTSD varied within study samples, from 4.2% to 44%. The studies 
in this integrative review utilized clinician diagnoses, both ICD-9 codes and medical 
records, as well as self-report measures, such as the PTSD patient checklist (PCL) scored 
using the diagnostic criteria based on Diagnostic and Statistical Manual IV-TR (DSM-
IV). Combat injury was found to be a significant risk factor for developing PTSD. Baker 
et al. (2009) established that injury during combat was significantly related to a positive 
PTSD screening among combat-injured veterans compared to those without injuries 
(odds ratio [OR], 3.14; 95% confidence interval [CI] [1.73, 5.71]). Despite the cross-
sectional approach and self-report of physical combat injury status, which resulted in a 




injury status and PTSD. Using the PCL, Phillips, LeardMann, Gumbs, and Smith (2010) 
found that individuals who experienced gunshot wounds or serious injury in combat were 
more likely to develop postdeployment PTSD compared to those without similar trauma 
(OR, 3.51; 95% CI [1.58, 7.77]). Phillips et al. provide stronger support for this 
relationship (Level 4), largely due to the prospective nature of the study. In addition, 
higher injury severity scores (ISS) were identified as a key variable for developing PTSD 
among military personnel. Initial findings by MacGregor, Corson et al. (2009) and 
MacGregor, Shaffer et al. (2009) suggested that combat-injured military personnel 
experienced higher rates of PTSD compared to uninjured peers. MacGregor, Tang, 
Dougherty, and Galarneau (2013) found that after adjusting for ISS, those injured in 
combat were twice as likely to develop PTSD compared to noncombat-injured military 
personnel (OR, 2.10; 95% CI [1.60, 2.75]). 
ISS is used to evaluate anatomic injury and severity ranging from 0 to 75, with 75 
indicating the greatest severity of injuries (Baker, O'Neill, Haddon, & Long, 1974). 
Combat-injured military personnel with, what MacGregor et al. (2013) defined as, an ISS 
of moderate (4–8) and serious-severe (9+) had significantly increased odds of developing 
PTSD (OR, 1.49; 95% CI [1.11, 2.00]) compared to those with mild (1–3) ISS (OR, 1.64; 
95% CI [1.01, 2.68]). Prior combat injury was also predictive of PTSD (OR, 1.96; 95% 
CI [1.22, 3.16]). Sandweiss et al. (2011) recognized that within the Millennium Cohort 
combat-injured population, a 3-unit increase in ISS translated to 16% increased likelihood 




summates to a clear connection between combat injury, injury severity, and subsequent 
development of PTSD, relative to noncombat-injured military personnel. 
Researchers identified an association between injury mechanism and PTSD. 
Investigators at a polytrauma rehabilitation center observed veterans with combat blast-
related injuries had significantly higher rates of PTSD (45.1% of sample) compared to 
those with noncombat-related injuries (2.1%) or injuries without blast exposure (11.8%, p 
< .001; Clark, Walker, Gironda, & Scholten, 2009). McLay, Webb-Murphy, Hammer, 
Volkert, and Klam (2012) reported veterans experiencing both blunt and penetrating 
combat injuries, had significantly higher rates of PTSD symptoms compared to those 
with no injuries or solely penetrating trauma (p < .05). In addition, Mora et al. (2009), 
identified that within their sample of burned combat-injured military personnel, 
individuals exposed to blast were more likely to screen positive for PTSD than those 
without blast injuries (OR, 3.27; 95% CI [1.17, 9.16]). This sample of severely burned 
military personnel exhibits that PTSD symptoms can potentially be a function of type, 
severity, and mechanism of injury. The increased odds of PTSD, from combat injury, 
further compounded by severity, indicates polytrauma may influence mental health 
outcomes. Not all studies included in this review measured PTSD severity, and many 
only reported the presence of PTSD, which limited the ability to examine severity of 
PTSD with injury severity. 
Depression and PTSD 
Depression rates within studies targeted for this review ranged from 7% to 27%, and 




and depression in combat-injured service members is complex, and some researchers 
contend that previous mental health diagnoses act as precursors to the development of 
PTSD. Sandweiss et al. (2011) identified that a preinjury mental disorder, including 
depression, was a risk factor for developing PTSD. Researchers screening for PTSD 
symptoms found those with one or more mental disorder at baseline had 2.52 times (95% 
CI [2.01, 3.16]) greater risk for postdeployment PTSD after injury. The prospective 
approach, employed by Sandweiss et al., provides a unique opportunity to examine 
depression prior to injury and offers strong evidence to support this predisposing 
relationship (Level 4). Similarly, MacGregor et al. (2013) documented that a mental 
health diagnosis within 1 year prior to deployment increased odds of developing PTSD 
following injury (OR, 2.69; 95% CI [1.50, 4.81]; Level 4). 
Although the aforementioned studies support a higher likelihood for PTSD with an 
existing mental disorder prior to combat injury, others purport that there is a bidirectional 
relationship between PTSD and depression. Several researchers identify depression as 
being a common mental disorder appearing with PTSD following trauma. Clark, Bair, 
Buckenmaier, Gironda, and Walker (2007) found PTSD evident in 44% and depressive 
disorders in 24% of their sample. Researchers following combat-injured military 
personnel transitioning from DoD to VHA care reported similar rates, for PTSD (38%) 
and depression (27%; Copeland et al., 2011). Similar work by Clark et al. (2009) 
identified elevated rates of PTSD and depression among polytrauma care seeking 
veterans who experienced combat blast related injuries (45.1%, 25.5%, respectively) 




exposure (11.8%, 14.7%). VHA researchers report that in a sample of veterans, those 
injured in combat with a PTSD diagnosis were significantly more likely to also meet 
depression criteria compared to those uninjured (p < .001; Baker et al., 2009). However, 
the relationship, whether causal-effect or bidirectional, could not be determined due to 
the cross-sectional nature of these studies (Level 6). Within a national sample of OEF and 
OIF veterans seeking care, Pugh et al. (2014) identified that depression was a significant 
comorbidity with PTSD for polytrauma veterans. Veterans presenting with “comorbidity 
clusters,” defined by the presence of polytrauma, PTSD, and depression were most likely 
to have adverse outcomes, as evidenced by the high likelihood of emergency care, 
compared to individuals in “comorbidity clusters” without both PTSD and depression 
(OR, 3.90; 95% CI [3.70, 4.10]). Pugh et al. (2014) claim that depression is a central 
comorbidity that contributes substantially to healthcare utilization and adverse outcomes 
for veterans. Pugh et al.’s large sample size (N = 191,797) strengthens support for this 
relationship (Level 4); however, this study fails to account for time since injury or 
symptom severity. 
The presence of PTSD and depression across VHA facilities, among combat-injured 
service members, demonstrates a need to investigate the interplay these two illnesses 
have on long-term health outcomes. Grieger et al. (2006) showed that early significant 
somatic symptom severity from combat injuries, as measured by the self-reported 15-item 
Patient Health Questionnaire, was associated with PTSD and depression diagnoses 7 
months postinjury. In a combat-injured cohort, individuals with high somatic symptom 




diagnoses when compared to their less symptomatic peers (<8). Individuals with higher 
somatic symptom severity 1 month after injury were more likely to develop PTSD (OR, 
9.10; 95% CI [4.10, 20.10]) and depression (OR, 5.70; 95% CI [2.40, 13.20]) 7 months 
later. These prospective findings by Grieger et al. provide evidence (Level 4) to support 
that initial symptom severity can potentially predict the development of mental health 
symptoms. 
Pain and PTSD 
Researchers examined pain severity, both immediately postinjury and throughout 
rehabilitation, and the potential role of pain management interventions in the 
development of PTSD. Holbrook, Galarneau, Dye, Quinn, and Dougherty (2010) 
established that morphine-based pain management, immediately following combat 
injuries, exerted a protective effect on the development of PTSD up to 2 years postinjury 
(OR, 0.47; 95% CI [0.34, 0.66]). Melcer et al. (2014) confirm the success of early pain 
management with morphine, over other medications, in reducing odds of developing 
PTSD up to 4 years after injury (OR, 0.40; 95% CI [0.17, 0.94]). Further, McGhee, 
Maani, Garza, Gaylord, and Black (2008) and McGhee et al. (2014) reported a lower 
prevalence of PTSD among injured service members who received ketamine during their 
surgeries compared to those who did not (p = .044). Findings from Buckenmaier et al. 
(2009) show early benefits of aggressive pain management include the reduced 
symptoms of anxiety and distress correlating with pain relief. These studies provide 
evidence for early effective pain control to reduce the development of PTSD and reduce 




Investigators evaluated pain and mental health symptoms long after initial injury. 
Stratton et al. (2014) revealed that baseline pain severity accurately predicted latent 
PTSD diagnoses, and PTSD severity predicted pain severity at 1-year follow-up (χ2 = 
3.66; p < .05). This prospective study design offers evidence to support this association 
(Level 4). In polytrauma rehabilitative centers, researchers identified pervasive needs for 
the treatment of co-occurring pain and stress disorders, such as PTSD (Clark et al., 2007, 
2009; Sayer et al., 2009). Pugh et al.’s (2014) analysis of “comorbidity clusters” 
concluded that pain demonstrated no consistent pattern in predicting adverse outcomes, 
unless comorbid with depression and PTSD. Individuals with all three comorbidities had 
the highest odds of adverse outcomes, such as homelessness (OR, 6.60; 95% CI [5.80, 
7.50]) and suicide-related behaviors (OR, 13.30; 95% CI [10.30, 17.20]) than other 
polytrauma cohorts. Adequate pain management after injury potentially influences PTSD 
symptoms across healthcare settings. 
Discussion 
This integrative review examines the complex relationship between pain, PTSD, and 
depression, seen in combat-injured OEF and OIF military personnel. Findings underscore 
the importance of assessing for potential comorbidities after combat injury. The post-
September 11, 2001 veteran population is projected to increase 46% by 2019, and while 
the VHA cares for millions of veterans, almost half seek care in civilian healthcare 
facilities (National Center for Veterans Analysis and Statistics, 2016). Nurses practicing 
in military healthcare facilities encounter service members and veterans injured in OEF 




the point of injury, to Level 5, at U.S. major military facilities, it is critical that they 
understand the consequences of combat injuries on physical and mental health (Bagg, 
Covey, & Powell, 2006). VHA and civilian nurses are also likely to care for veterans who 
sustained combat trauma, and they too must combine scientific knowledge, 
interdisciplinary collaboration, and patient and family advocacy to improve patient 
outcomes. Early recognition of trauma-related pain, PTSD, and depression, and 
interventions aimed at reducing their severity are essential to combat casualty and trauma 
care. Nurse Practitioners and Certified Registered Nurse Anesthetists are also practicing 
in military, veteran, and civilian trauma care settings and are positioned to assume 
responsibilities for the management of combat-injury related pain (Schoneboom et al., 
2016). 
Mental Health 
There is an established association between combat exposure and mental health, 
particularly PTSD (Hoge, Riviere, Wilk, Herrell, & Weathers, 2014). However, the 
causal relationship between combat injury and subsequent development of PTSD is not 
clear. Numerous factors contribute to the preinjury, acute injury, and postinjury stages 
that can influence the development of PTSD among combat-injured military personnel. 
Several studies demonstrate the need to screen and identify predeployment risk factors, 
such as mental disorders and previous traumatic exposures. Researchers identified 
associations between injury severity (Baker et al., 2009; MacGregor, Corson et al., 2009; 
MacGregor, Shaffer et al., 2009; MacGregor et al., 2013; Sandweiss et al., 2011) and 




2008; McGhee et al., 2014; Melcer et al., 2014). Mechanistic type of injury, particularly 
blast or in combination with blunt and penetrating trauma, can influence the development 
of postinjury mental health symptoms (e.g., PTSD and depression; Clark et al., 2009; 
McLay et al., 2012; Mora et al., 2009; Pugh et al., 2014). Risk of developing PTSD is 
higher in those experiencing combat-related trauma, compared to individuals with 
noncombat-related injuries, and risk increases with injury severity (MacGregor, Corson et 
al., 2009; MacGregor, Shaffer et al., 2009; Sandweiss et al., 2011). 
Several studies address the presence of depression preceding combat injury and 
subsequent development of PTSD (Clark et al., 2007; MacGregor et al., 2013; Sandweiss 
et al., 2011). Others described comorbid depression and PTSD following injury (Clark et 
al., 2009; Grieger et al., 2006). In civilian populations, individuals with comorbid PTSD 
and depression may experience more severe depression, increased healthcare cost, and 
lower physical functioning than individuals with either condition alone (Campbell et al., 
2007). The foundation of research examining PTSD and depression symptoms as 
comorbidities highlights the need for further analysis of these relationships in combat-
injured populations. 
Pain in the Context of Combat Injury Care 
Pain is one of the most frequently reported symptoms after combat injury. Pain 
management, in addition to alleviating postinjury acute pain, can reduce symptom 
severity of other physical and mental symptoms caused by trauma (Clark et al., 2007). 
Acute pain can be substantial when considering the extent of injury polytrauma entails. 




cause irritability, social withdrawal, depressed mood, sleep changes, and lead to 
disruption in social relationships (Katz & Rothenberg, 2005). VHA investigators report 
over one third of polytrauma survivors experience multiple types of chronic pain (e.g., 
neuropathic, phantom limb), and over two thirds of combat-injured veterans need pain 
management interventions throughout polytrauma rehabilitation (Clark et al., 2007, 2009; 
Copeland et al., 2011; Sayer et al., 2009). The prevalence of chronic pain and continued 
pain management needs in this population further emphasizes the urgency for early acute 
pain management. 
Early pain interventions may mitigate the lasting effects of acute trauma that lead to 
the development of chronic pain by interrupting the cascade of events triggering 
neurotransmitter release, intracellular responses, and neuropsychological response. For 
example, Buckenmaier et al. (2009) and Buckenmaier, Mahoney, Anton, Kwon, and 
Polomano (2012) found that incorporating aggressive multimodal regional analgesia after 
injury significantly reduced pain intensity in combat-injured soldiers compared to 
soldiers receiving standard pain management. Clinical characteristics of injury (e.g., 
severity and mechanism) are associated with the risk of developing postinjury PTSD and 
depression (Grieger et al., 2006), as well as acute and chronic pain. A significant, but 
weak, relationship exists between ISS and acute pain severity (Fowler et al., 2011), and 
injury type (e.g., blast), which may interfere with pain relief (Clark et al., 2009). Given 
the disabling effects of undermanaged mental health conditions and comorbid chronic 
pain, early assessment and management of polytrauma related symptoms are critical. A 




chronic pain experienced greater pain-related disability than veterans with chronic pain 
alone. However, the study sample did not include combat-injured veterans. OEF and OIF 
veterans with comorbid PTSD and chronic pain experienced greater pain-related 
disability than veterans with chronic pain alone (Outcalt et al., 2015). Unlike previous 
polytrauma reviews (Dobscha et al., 2009), this review highlights the multidimensional 
clinical presentations of pain in relation to depression and PTSD. 
Limitations 
There are limitations to the research included in this review. First, the literature has 
no unified means of measuring PTSD, depression, and pain postinjury, or even injury 
itself. Researchers utilized the ISS, however many relied on self-reported injury status. 
PTSD screening tools varied, with some using clinician diagnoses and others patient self-
reports. Updated PTSD diagnostic criteria in the DSM-5 may limit the ability to 
understand the predictive factors leading to positive screenings of PTSD among military 
populations. However, researchers have demonstrated the consistency between DSM-IV 
and DSM-5 criteria within U.S. veterans (Miller et al., 2013). This affirms a consistency, 
at least in veteran populations, for PTSD assessments and the ability to compare previous 
studies to future work. Second, study designs affect overall generalizability and quality of 
findings. The few prospective studies and numerous retrospective studies, which the 
applied criteria consider to be of lower evidence quality, speak to the difficulties in 
conducting research investigating combat-injured populations. The inherent limitations of 
retrospective studies hinder the ability to identify causal relationships. Finally, small 




the care of all combat-injured persons. For instance, Grieger et al. (2006) and Stratton et 
al. (2014) experienced attrition rates of 40% and 47%, respectively. This review 
demonstrates the necessity of understanding risk factors that complicate the relationship 
between pain and mental health, postinjury. 
Future Directions 
Improved survival rates after polytrauma warrant a need for more prospective 
longitudinal studies to capture these unprecedented symptom trajectories. The inclusion 
of comprehensive standard assessment measures is vital to optimizing the care of combat-
injured persons and determining predictors of long-term health outcomes. Currently, 
initial trauma measures are valuable clinical tools, but not comprehensive to 
understanding long-term symptom trajectories. Several articles identified the value initial 
traumas measures, specifically ISS, can have in identifying individuals at risk of 
developing PTSD, however, civilian researchers have found that increasing objective 
injury severity is not directly related to the development of PTSD (Richmond et al., 
2011). The integration of uniform health screening metrics in the recent Pain Assessment 
Screening Tool and Outcomes Registry (PASTOR), developed by the Pain Management 
Task Force, addresses the use of standardized measures for research and clinical care 
(Cook, Buckenmaier, & Gershon, 2014). PASTOR incorporates the National Institutes of 
Health's Patient-Reported Outcomes Measurement Information System (PROMIS®) 
Measures. For example, the Defense and Veterans Pain Rating Scale (DVPRS) has 
already undergone testing in military and VHA facilities (Polomano et al., 2016). 




for assessment across all transitions of care, phases of recovery, and reintegration into 
civilian life. Nurses are in a unique position to implement assessment measures and 
incorporate standardized measures in their clinical and research practices. 
Conclusions 
This integrative review examined the complex clinical presentations and 
interrelationships of pain, PTSD, and depression experienced by combat-injured military 
personnel and veterans. Injury severity is a contributing factor to the development of 
PTSD following combat injury among OEF and OIF military personnel and veterans. 
Pain severity and early symptom management influence the development of PTSD 
following combat injury. Depression appears to be both a contributing risk factor to 
postinjury PTSD, as well as a comorbidity. Pain remains a major concern for polytrauma 
survivors long after the initial injury. This paper contributes an analysis of empirical 
research that specifically examines the relationship among PTSD, depression, and pain 
outcomes for military personnel not only exposed to combat but also those injured 












Table 2-1: Summary of Studies 
Citation Objective Sample (setting) Study design Relevant findings Relationships of key outcomes of interest 
Quality of 
evidence a 




factors, military service, 
combat-related injury, and 
mental health symptoms 
N = 339 
OEF/OIF veterans 
(VHA) 
Cross-sectional Those who endorsed being 
injured during combat were 
more likely to screen positive 
for PTSD compared to those 
with no injuries 
About 37% of the sample 
screened positive for PTSD 
and about 43% reported 
having depressed mood within 
the previous month 
The prevalence of disease 
burden and severity for both 
depressive mood and PTSD is 
higher in those with combat 




et al. (2009) 
Evaluate pain severity and 
emotional status of injured 
soldiers 





Mixed methods Average and worst pain scores 
were negatively correlated to 
pain relief during transport 
Average pain relief in 24–48 
hr after injury was less than 
50% but those with a 
continuous peripheral nerve 
block reported better pain 
relief than those without one 
Higher pain intensity scores 
correlate with higher anxiety, 
distress, and worry during 
transport and may be of 
consideration for how pain 
management can influence early 




et al. (2012) 
Quantify patient-reported 
pain outcomes following 
acute pain service 
interventions 






Patients receiving peripheral 
nerve block reported better 
overall pain control compared 
to those receiving epidural or 
systematic analgesia 
The analgesic interventions 
implemented by acute pain 
service reduced patient-
reported pain severity over the 
first 24 hr following combat 
injury 
Overall mean percent reduction 
in pain intensity from time after 
initial injury to postacute pain 
service interventions prior to air 
evacuation was 60%, thereby 
indicating adequate acute pain 
assessment and management are 
feasible after injury 
Level 6 
Clark et al. 
(2007) 
Describe innovative 
approaches for improving 
pain care provided to 
OEF/OIF military personnel 






Cross-sectional Regional anesthesia and 
continuous peripheral nerve 
block are most often used to 
manage pain after combat 
injury 
Common mental health 
concerns for polytrauma 
The comorbid presentations of 
pain, PTSD, and depression are 
seen in polytrauma care settings 





Table 2-1: Summary of Studies 
Citation Objective Sample (setting) Study design Relevant findings Relationships of key outcomes of interest 
Quality of 
evidence a 
service members are PTSD, 
adjustment disorder, and 
depression in this sample 
Clark et al. 
(2009) 
Compare physical and 
emotional treatment 
outcomes of service 
members who sustained 
polytrauma injuries 
secondary to blast exposure 
compared to soldiers injured 
by other mechanisms 








PTSD was significantly more 
common among combat/blast 
injured cohort 
Functional independence 
measure scores were 
correlated to pain intensity 
scores for combat/blast 
injuries 
Those with combat/blast 
injuries had higher rates of 




significantly less improvement 
in pain severity 
Injury mechanism, specifically 
blast, is associated with a 
broader spectrum of injuries, 
reduced improvements in pain 
intensity after treatment, and 
higher rates of psychiatric 
disorders 
Level 4 
Copeland et al. 
(2011) 
Assess care transitions from 
DoD to VHA care and 
subsequent psychiatric care 
of combat-injured OEF/OIF 
veterans 





In the sample, 38% sought 
care for PTSD symptoms and 
27% for depression in the 
VHA, whereas in Department 
of Defense care, only 21% 
received a mental health 
diagnosis of any kind 
In the VHA setting, 65% of 
sample received pain 
medication 
The coexistence of PTSD, pain, 
and depression in combat-injured 
veterans seeking VHA care 
suggests a delay in development 
or recognition of these trauma 
symptoms 
Level 4 
Fowler et al. 
(2011) 
Examine the relationship of 
pain, injury, severity, and 
physiologic response in 
combat-injured soldiers 






Pain scores were not related to 
physiologic parameters 
ISS was proportional to the 
pain experienced of wounded 
soldiers 
Increasing ISS maybe 
proportional to pain scale 
responses in wounded soldiers 
but not for physiological 






Table 2-1: Summary of Studies 
Citation Objective Sample (setting) Study design Relevant findings Relationships of key outcomes of interest 
Quality of 
evidence a 
Grieger et al. 
(2006) 
Examine rates, predictors, 
and course of PTSD and 
depression among seriously 
injured soldiers following 
hospitalization 
N = 243 
OEF/OIF soldiers 





High severity of physical 
problems at 1-month 
postinjury was significantly 
associated with a diagnosis of 
PTSD and depression over 
time 
Majority of participants with 
PTSD or depression at end of 
follow-up period (7 months) 
did not qualify for an initial 
diagnosis at 1 month after 
injury 
Early severity of physical 
combat injuries, including pain 
severity, is strongly associated 
with the latent development of 
PTSD or depression 
Level 4 
Holbrook et al. 
(2010) 
Study effect of morphine 
use during early 
resuscitation on developing 
PTSD in injured military 
personnel 





The use of morphine 24 hr 
after injury was significantly 
associated with reduced risk of 
PTSD compared to those who 
did not receive morphine 
Aggressive pain management in 
the immediate postacute injury 
period, specifically the use of 
morphine, is strongly associated 
with lower risk of PTSD 
Level 4 
MacGregor et al. 
(2009) 
Characterize the relationship 
between injury-related 
factors and PTSD among 
battle-injured military 
personnel 






As ISS increases, the odds of 
being diagnosed with a mental 
health illnesses increases 
Serious and severe ISS scores 
increased the odds of being 
diagnosed with PTSD 
Injury severity may be a 
significant predictor of PTSD 
and other mental health 
diagnoses, including depression 
up to 6 months after initial injury 
Level 4 
MacGregor et al. 
(2009) 
Describe prevalence of 
PTSD and self-reported 
mental health symptoms 
among OIF combatants 






Greater risk for PTSD and 
other mental health diagnoses, 
including depression, among 
battle-injured than nonbattle-
injured 
Injury severity indicated 
greater risk for developing 
PTSD or other mental health 
diagnoses 
Compared with nonbattle 
injuries, those with battle 
injuries had a greater risk of 
PTSD and other mental health 
diagnosis, such as depression, 
and there was a positive 
association with injury severity 




MacGregor et al. 
(2013) 
Examine the association 
between deployment-related 
injury and PTSD among 





Predictors of PTSD among 
those with battle injuries 
included moderate to serious-
The presence of mental health 
conditions, such as depression, 





Table 2-1: Summary of Studies 





(CTR EMED) severe ISS, prior battle injury, 
and mental health diagnosis 
within 1 year predeployment 
Battle injury is a significant 
predictor of PTSD compared 
to those not injured in battle 
factors for PTSD after 
experiencing serious-severe 
combat injuries 
McGhee et al. 
(2008) 
Investigate the prevalence 
of PTSD in OEF/OIF 
service members treated for 
burns and administered 
perioperative ketamine 






The prevalence of PTSD was 
lower among those receiving 
ketamine compared to those 
who did not receive ketamine 
Pharmacological pain 
management interventions, 
specifically the use of ketamine 
after combat-related burn 
injuries, may act as a protective 
factor in developing PTSD 
Level 4 
McGhee et al. 
(2014) 
Evaluate relationship 
between early acute pain 
scores and PTSD in burned 
soldiers 






Despite increased ISS in 
combat injuries, individuals 
exposed to ketamine 
experienced no greater risk of 
developing PTSD as less 
severely injured soldiers 
without ketamine 
Decreased PTSD development 
may be related to effective pain 
control, specifically the use of 
ketamine after burn injuries 
Level 6 
McLay et al. 
(2012) 
Determine whether different 
injury mechanisms predict 
the risk and severity of 
PTSD symptoms 




Center, San Diego) 
Retrospective 
analysis 
Service members with blunt 
and combined (e.g., blunt and 
blast) mechanisms of injury 
had higher symptom severity 
of PTSD than those with no 
injury or only penetrating 
injures 
Mechanism of combat injuries 
(blunt trauma and blast 
exposure) is associated with high 
rates of PTSD. 
Level 6 
Melcer et al. 
(2014) 
Examine short-term and 
long-term psychological 
outcomes among combat 
amputees 





Significantly reduced odds of 
PTSD among amputees 
receiving intravenous 
morphine compared to 
fentanyl over 4 years 
postinjury 
PTSD prevalence increased 
after first-year postinjury 
while rates of other 
The adequate management of 
acute pain with morphine has 
shown a potentially protective 
effect, compared to fentanyl, on 
subsequent development of 






Table 2-1: Summary of Studies 





Mora et al. (2009) Examine the association 
between primary blast 
injuries and PTSD in burned 
combat casualties 





IED wounded participants 
with burns and blast related 
injuries had increased odds of 
having a PTSD diagnosis 
compared to those with just 
blast injuries 
Risk of developing PTSD is a 
function of injury type, severity, 
and mechanism of injury (e.g., 
blast) 
Level 6 
Phillips et al. 
(2010) 
Explore the relationship 
between specific combat 
exposures and other life 
experiences with 
postdeployment PTSD 
N = 706 
Marines 
(Marine Corps 





Marines with gunshot wounds 
or serious wounds were more 
likely to screen positive for 
PTSD compared to those who 
had neither 
Rates of mental health morbidity 
among marines is due in part to 
the increased risk of PTSD 
associated with severe combat 
injury as well as individuals’ 
traumatic psychological 
exposures, such as violence, 
prior to deployment 
Level 4 
Pugh et al. (2014) Identify comorbidity 
clusters among veterans 
seeking care for 
deployment-specific 
diagnoses, including combat 
injuries 






Six clusters were identified: 
(a) PCT, depression, chronic 
disease; (b) PCT; (c) mental 
health and substance abuse; 
(d) sleep, amputation, chronic 
disease; (e) pain and moderate 
PTSD; (f) relatively healthy 
Depression was a significant 
comorbidity and characterized 
by PTSD when present in 
cluster A and C and 
individuals were most likely to 
have adverse outcomes and 
healthcare utilization 
The comorbid nature of 
depression, PTSD, and pain 
compounds in veterans seeking 
care in the VHA as evident in 
increased complexity of care 
needs and care utilization 
Level 4 
Sandweiss et al. 
(2011) 
Prospectively assess the 
relationship of 
predeployment psychiatric 
status, injury severity, and 
postdeployment PTSD 
N = 22,630 
Service member 





After adjusting for baseline 
PTSD and all other exposure 
variables, the odds of 
postdeployment PTSD 
symptoms were greater in 
those with one or more 
Diagnosed mental health 
conditions, including depression, 
potentially act as predisposing 






Table 2-1: Summary of Studies 




Research Center in 
San Diego, 
California) 
defined baseline psychiatric 
disorders compared to those 
with no psychiatric disorders 
After adjusting for baseline 
PTSD symptoms, the odds of 
postdeployment PTSD 
symptoms were 16% greater 
for every 3-unit increase in 
ISS 
Sayer et al. 
(2009) 
Describe the medical 
rehabilitation needs of 
OEF/OIF inpatients with 
combat injuries 








Pain and psychiatric 
symptoms were significant 
complaint during inpatient 
stay and all patients received 
pain management 
interventions 
Pain was present in 100% of 
the sample and at 50% 
experienced mental health 
symptoms 
Pain is pervasive in veterans 
following polytrauma and 
requires optimal management so 
as to prevent interference in 
physical and psychological 
rehabilitation efforts 
Level 6 
Stratton et al. 
(2014) 
Investigate the longitudinal 
course of pain and PTSD 
symptoms following blast 
exposure 






PTSD scores and symptoms 
exert a strong influence on 
pain scores 
PTSD scores at baseline 
predict patient-reported pain 
scores at 6 and 12 months, 
whereas baseline pain scores 
only predict PTSD scores at 6 
months 
Pain and PTSD are significantly 
associated with one another 
across the care continuum when 
present indicating optimal 
management early on after 
diagnosis can influence 
symptom severity longitudinally 
Level 4 
Note. PTSD, posttraumatic stress disorder; IED, improvised explosive device; ISS, Injury Severity Score; PCL-M, PTSD checklist military version; OEF/OIF, Operation Enduring Freedom/Operation 
Iraqi Freedom; VHA, Veterans Health Administration; CTR EMED, Combat Trauma Registry Expeditionary Medical Encounter Database; JTTR, Joint Theater Trauma Registry. 
a Level of evidence determined using rating system for the hierarchy of evidence (Melnyk & Fineout-Overholt, 2011). The hierarchy is a seven-tier scale, with the best evidence receiving the strongest 
rating. The strongest evidence to base clinical practice on is rated Level 1 and includes both systematic reviews and meta-analyses of randomized controlled trials or evidenced-based clinical practice 
guidelines based on systematic reviews of randomized controlled trials. Level 2 comprises evidence from well-designed randomized control trials, Level 3 evidence comes from controlled trials with no 
randomization. Level 4 contains cohort and case-control research studies. Level 5 evidence is produced from systematic reviews of descriptive and qualitative studies. Level 6 includes both single 
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Longitudinal Trajectories of Pain and Post-Traumatic Stress Symptoms After 
Exposure to Regional Anesthesia Following Combat Injury 
Abstract 
Unrelieved acute pain after combat injury can contribute to the development of chronic 
pain and post-traumatic stress disorder (PTSD). There are few studies evaluating 
longitudinal presentations of pain and PTSD symptoms after combat-injured patients 
receive acute pain management. This prospective observational cohort study evaluated 
the association of early pain management and PTSD symptom trajectories on pain 
experiences in 288 Operation Enduring Freedom and Operation Iraqi Freedom 
(OEF/OIF) combat-injured military personnel who received regional anesthesia (RA) or 
standard pain management approaches for pain management. Pain and PTSD symptoms 
are moderately to strongly (rs > .31) positively correlated up to 21 months after injury (P 
< .05). Linear mixed effects models indicate that both initial pain intensity (P < .001) and 
initial PTSD symptom severity are strongly associated with pain intensity and 
interference (P < .001). Moreover, worsening PTSD symptom trajectories are 
significantly associated with higher average pain and pain right now, after controlling for 
injury severity, RA receipt, and time from injury to observation (P < .02). There are 
short- and long-term reductions in pain intensity with early RA administration following 
combat injury (P < .01). Evidence indicates that RA is an effective intervention and that 
both pain and PTSD symptoms should be evaluated and addressed on an ongoing basis in 
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Perspective: RA is an effective pain intervention for trauma care and is associated with 
long-term reductions in pain intensity. Findings underscore the need for implementing 
early acute pain management interventions and for continued evaluation of pain-related 
outcomes and comprehensive mental health treatment approaches beyond one year after 
injury.  
Keywords: pain interference, pain intensity, post-traumatic stress disorder (PTSD), 








Significant advancements in combat casualty care have increased survival rates in 
American military personnel sustaining complex combat injuries during Operation 
Enduring Freedom and Operation Iraqi Freedom (OEF/OIF).1,2 The severity of many of 
these combat related-injuries warrant early and sustained pain management. However, 
acute pain services delivered by pain management specialists capable of providing early 
multimodal analgesics in the immediate aftermath of injury and throughout the military 
evacuation chain are still needed as part of the combat casualty care.3,4 Evidence suggests 
that hyperstimulation of central neuronal pathways and unrelieved acute pain induces 
neural plasticity in the central nervous system and leads to maladaptive neuropathological 
remodeling after injury.5,6 This rewiring may result in chronic pain and elevate 
subsequent risk for mental health conditions, such as post-traumatic stress disorder 
(PTSD), for patients who have experienced unrelieved severe pain after traumatic 
injury.7-9 To date, there have been few longitudinal studies of this association after 
combat-related injury. 
Chronic pain and PTSD are believed to share a vulnerability pathway that, when co-
existing, amplify exacerbations of symptoms, increase pain intensity, and pain 
interference.10-13 Pain intensity is a valuable measure of how severe pain is, and pain 
interference is a measure of how pain impacts physical, social, and emotional 
functioning.14 Severe persistent PTSD symptoms, lasting for over one month after 
witnessing or experiencing a traumatic event (e.g. combat-related injury) are diagnosed 




PTSD, compared to an estimated 11%-20% in the general OIF/OEF veteran 
population.16,17 Additionally, 50%-80% of OEF/OIF veterans diagnosed with PTSD also 
report chronic pain.17 PTSD is believed to be a risk factor for transitioning from acute to 
chronic pain.18 PTSD symptom severity may be a source of variability in how veterans 
affected by chronic pain numerically rate their pain experience.19 Veterans with 
significant PTSD symptomatology and chronic pain often experience increased pain 
intensity, pain interference, and pain-related disability.20,21 Increased PTSD symptom 
severity is believed to significantly amplify pain perception after injury, both in civilian22 
and OEF/OIF23 veteran populations. Others have found trauma related pain is associated 
with worse PTSD symptoms in veteran populations.25  
The mutual presence of PTSD and chronic pain in OEF/OIF veterans has been 
investigated since the onset of these conflicts.26-28 However, the relationship of pain and 
PTSD in OEF/OIF combat-injured veterans is primarily examined using cross-sectional 
or retrospective designs and PTSD is dichotomized as present or absent without 
evaluating symptom severity or symptom trajectories.29,30 The few longitudinal 
investigations of pain and PTSD symptom severity in OEF/OIF military personnel and 
veterans are limited to one year follow up time periods, do not adjust for time since 
injury, depend on self-reported injury status, and do not consider early pain 
interventions.31-34 Trajectories of PTSD, or longitudinal changes in total symptom 
severity, are generally characterized to be low-stable (resilient), worsening (chronic), or 
improving over time (recovery/remitting), with numerous variations in these trajectories 




presentations seen in OEF/OIF military personnel and veterans is of the low-stable 
symptom trajectory.35 Considering the significant impairment symptoms can have on 
physical and social functioning, ongoing evaluation of PTSD symptoms in this 
population is still warranted, even for individuals whose symptoms do not meet 
diagnostic criteria. Changes in PTSD symptoms, even at early stages after combat injury, 
have the potential to inform future care planning and monitoring for pain severity and 
interference. 
Early multimodal pain interventions following serious injuries can mitigate the lasting 
effects of tissue trauma. Regional anesthesia (RA) has been shown to adequately provide 
acute pain management for modern combat casualties in the austere environment40,41 and 
throughout transportation,42 as well as safely deliver anesthesia and analgesia during the 
preoperative, intraoperative, and postoperative periods.43 Use of RA is postulated to 
reduce the risks of post-surgical complications after injury.42,50,55 Benefits of utilizing 
RA, over systemic analgesics and anesthetics, include the avoidance of intubation for 
mechanical ventilation, lower risk of hemorrhage, and more optimal postoperative 
analgesia.49,55,56 Moreover, observational studies have suggested early pain management 
after combat-injury, with either morphine44,45 or ketamine,46 has a protective effect on the 
development of PTSD. These early pain interventions could potentially influence PTSD 
trajectories, which in turn effect pain intensity and interference. RA, particularly as a 
peripheral nerve block, can be an optimal mechanism for trauma patients with major limb 
injuries due to the directed delivery of analgesics without systemic effects. Over half of 




extremity injuries are serious and potentially fatal.48 The purpose of this secondary 
analysis is to evaluate the association of RA and PTSD symptom trajectories with pain 
intensity and interference in a sample of combat-injured OEF/OIF military personnel and 
veterans.  
Methods 
Study Design  
The Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) is a 
prospective observational cohort study that investigated the effects of early aggressive 
RA following major combat-related limb injuries sustained in the OEF/OIF conflicts by 
United States (U.S.) military personnel and the subsequent patient-reported pain 
outcomes. RAMBPOS enrollment began in October 2007 and data collection concluded 
in September 2014. The research team at Corporal Michael J. Crescenz Veterans Affairs 
(VA) Medical Center (Philadelphia, PA) collected participants’ patient-reported 
outcomes via telephone. Attempts were made to collect patient-reported outcomes 
monthly for individuals joining the study within the first 6 months after injury and every 
3 months thereafter, for up to 24 months after combat injury. Individuals could join the 
RAMBPOS study at any time after injury. Interviews with participants collected data on 
pain intensity and interference, and mental health symptom severities, including PTSD. 
Medical record review from The Department of Defense’s (DOD) Joint Theater Trauma 
Registry, now known as the DOD Trauma Registry, provided clinical and military career 
information, including date of injury, pain management and treatment status, and Injury 




Department of Veterans Affairs (VA) Medical Center Research & Development 
Committee and the University of Pennsylvania. 
Participants 
Participants were recruited from the former Walter Reed Army Medical Center 
(Washington, DC), the current Walter Reed National Military Medical Center (Bethesda, 
MD), and the U.S. Army Institute of Surgical Research at Brooke Army Medical Center 
(San Antonio, TX). Participants with a combat-related major injury in one or more 
extremities requiring hospitalization were eligible for enrollment in RAMBPOS. 
Exclusion criteria included: moderate and severe traumatic brain injury (TBI), cognitive 
deficits, inability to concentrate, poor judgment and impulse control, substantial hearing 
loss, and bilateral upper extremity amputation with no alternate means to complete the 
survey forms. Of the Six-hundred and eighty-seven (N = 687) combat-injured military 
service members screened while inpatients or in rehabilitation, 301 did not meet 
eligibility criteria for study enrollment. Three-hundred and eighty-six (N = 386) 
participants consented, enrolled and provided data in RAMBPOS. Analysis was only 
possible on participants with two or more patient-reported pain outcomes and PTSD 
assessments, and 98 participants did not meet these criteria. The final sample for this 
secondary analysis included 288 combat-injured military personnel with two or more 
pain and mental health assessments within 24 months after injury. There was a mean of 




Regional Anesthesia  
Under ultrasound imaging an epidural or a peripheral nerve block, either intermittent or 
continuous, is placed near a cluster of nerves through which RA is delivered to an area of 
the body that requires localized pain management, such as a severely injured 
extremity.53,54 RA, specifically peripheral nerve blocks, have been used to manage pain in 
the austere environment, during transportation, preoperatively, and during acute care 
following injuries in both Iraq and Afghanistan.3,41,42 Whether individuals received RA, 
or not, was based on their proximity to a forward operating base, within a combat support 
hospital, with a trained military anesthesia provider, and acute pain service deployed at 
time of injury, as well as the availability of these services upon arrival in a U.S. military 
hospital. RAMBPOS individuals who received RA within 14 days after injury were 
compared to individuals who did not receive RA within 2 months after injury. RA receipt 
was confirmed in the medical and surgical records upon enrollment. Participants not 
receiving RA still received standard pain management including systemic multimodal 
pain management throughout transportation and acute care at U.S. military medical 
facilities. These consented and enrolled participants constitute the No RA cohort. RA was 
the independent variable for this study.  
Measures 
Brief Pain Inventory 
The Brief Pain Inventory (BPI) is a 9-item pain assessment tool measuring pain intensity 
and pain interference.57 One of the strengths of the BPI is its ability to measure the 




their pain experience, worst pain and least pain, to better contextualize the pain they are 
reporting at time of assessment. Respondents rate their worst pain in the past 24 hours, 
least pain in the last 24 hours, average pain, and pain right now (at time of assessment), 
intensity on a scale of 0-10, with 0 being “no pain,” and 10 being “pain as bad as you 
could imagine.” The interference section of the measure includes ratings for the degree to 
which pain interferes with general activity, mood, walking, work, relationships, sleep, 
and enjoyment of life from 0, “pain does not interfere”, to 10, “interferes completely”, 
collectively known as pain interference.58,59 The BPI has been validated to accurately 
assess for noncancer pain,60 chronic nonmalignant pain,61 and individuals experiencing 
pain from orthopedic injuries.62 BPI pain intensity measures for worst, least, average, and 
pain right now were each examined as primary outcomes. Pain interference was also a 
primary outcome and scored as the mean of the seven interference items (i.e. general 
activity, mood, walking, work, relationships, sleep, enjoyment of life).  
Post-traumatic Stress Disorder Checklist 
The Post-Traumatic Stress Disorder Checklist Military Version (PCL-M) is a 17-item 
validated PTSD assessment instrument. Respondents rate the extent to which they have 
experienced each of the 17 diagnostic symptoms for PTSD outlined in the Diagnostic and 
Statistical Manual of Mental Disorders IV (DSM-IV), as related to stressful military 
experiences.63-65 Total symptom severity scores are computed by adding the 17 items, 
with each item scored based on the degree to which the symptoms bothered a participant 
over the past month from “not at all” (1) to “extremely” (5). Total PCL-M scores range 




National Center for PTSD recommends a minimum threshold of 30 for total symptom 
severity score on the PCL-M be considered meeting PTSD diagnostic criteria.66 
RAMBPOS participants completed the PCL-M as part of the battery of mental health 
assessments provided by the Philadelphia VA Medical Center’s Behavioral Health Lab, 
which is part of the VA’s measurement based mental health care initiative. PTSD was 
examined as a covariate in this analysis.  
Other Characteristics  
The screening and baseline interviews assessed sociodemographic characteristics (e.g. 
age, gender, race, ethnicity, education, marital status). Other covariates included the 
length of hospitalization (in days), number of deployments, and Injury Severity Score 
(ISS).  
Injury Severity Score  
The ISS is a scale used to evaluate anatomic injury severity following traumatic injury 
that ranges from 0 to 75, with 75 indicating the greatest severity and incompatible with 
life.67,68 The ISS is based on an Abbreviated Injury Scale (AIS) score allocated to the six 
body regions (i.e. Head, Face, Chest, Abdomen, Extremities, and External). The highest 
AIS score in each body region is used. The three most severely injured body regions 
scores are squared and summed to produce the ISS. The ISS correlates linearly with 
mortality, morbidity, hospital stay and other measures of severity. In this analysis ISS 
was examined both linearly and categorically as Minor (£9), Moderate (10-15), 
Moderate/Severe (16-24), and Severe/Critical (³25). The ISS is one of the most 








Univariate descriptive statistics for both the RA and No RA cohort were calculated. 
Bivariate statistical tests were conducted to assess if there were any statistically 
significant differences between sociodemographic and injury variables, with and without 
RA administration. Between group differences were compared with independent sample 
t-tests or chi-square tests at baseline. Average PCL-M scores were compared between RA 
cohorts.  
PTSD Symptom Severity and Pain Intensity and Interference Correlations 
The positive relationship between PTSD and pain intensity and interference was visually 
inspected using bivariate scatter plots (Appendix Figures A3-1 to A3-5). Spearman’s 
correlation estimates (rs) were calculated at each time point (i.e. month since injury to 
observation), due to the non-normal distributions of PCL-M scores (Shapiro-Wilk = .834, 
P < .001). This was done to assess the monotonic relationship between pain intensity and 
interference, each separately, with PTSD symptom severity, using the PCL-M. 
Correlation coefficients were categorized based on well-established guidelines.70  
PTSD Symptom Trajectories  
For this analysis, PTSD symptom severity was examined based on PCL-M total symptom 
severity scores. Models included participants’ first PCL-M scores in the study, referred to 




and PTSD.  However, baseline values included in the modeling controlled for 
intraindividual variability. Next, PTSD symptom trajectories were calculated as the 
overall difference in an individual’s first PCL-M score and an individual’s last observed 





PTSD symptom trajectories were characterized (Figure 3-1) from a continuous 
variable into an indicator term: (1) individuals with a worsening trajectory (e.g. PTSD 
symptoms increase over time), (2) individuals with stable trajectories (e.g. PTSD 
symptoms do not get better or worse), and (3) individuals with an improving trajectory 
(e.g. PTSD symptoms decrease over time). This was done to maximize the number of 
participants in the improving and worsening trajectories to better assess the effects of 
either trajectory. Sensitivity analyses were conducted with a wider caliber for the stable 
trajectory (See Appendix Table A3-2). Distribution of PTSD symptom trajectory 
categories were examined across each RA cohort. Of note, unadjusted least squares linear 
regression slopes were fitted and found to be of poorer fit than using the two-point 
derived slopes to estimate pain outcomes (Likelihood-ratio test, c2= 35.96, P < 0.001).   
Time 
Time was defined as the number of months since injury that a pain outcome measure was 
observed (i.e. months 0 to 24). When used as a continuous random-effect in the model, 
time accounts for both within and between subject variability in point estimates. All 




months. Therefore, a random intercept unique to each individual was used in the model 
parameter estimates. An indicator variable for time since injury and time to first 
observation in the study, known as the study entry cohort, was included in the model to 
account for potential selection bias. The study entry cohorts were categorized as less than 
6 months, between 6-12 months, or over 12 months since injury. The majority of 
participants, 76.74%, entered the study within 6 months of injury, 15.97% entered 
between 6 months to a year after injury, and 7.69% of participants entered over a year 
after injury.  
Mixed Effect Models 
Linear mixed effects models examined whether longitudinal progression of the outcomes, 
pain intensity and pain interference, are associated with an individual receiving RA and 
PTSD symptom trajectories. Linear mixed effects models are extensions of simple linear 
models, such as linear regression, and incorporate both fixed and random effects.71,72 This 
approach accounts for collinearity between individuals’ repeated outcome measures. 
First, bivariate models were fit to assess the association of each fixed effect (e.g. RA 
receipt status, ISS, length of hospitalization) to pain outcomes. A forward stepwise 
variable selection process was utilized. Goodness of fit for each model was assessed 
using Akaike information criterion (AIC).73 Each model includes a random intercept and 
slope to account for individual differences in the time between injury to observation (i.e. 
the number of months after injury that the outcome measure was recorded per person). 
Both a model with random intercept only, and a model with random slope only were 




model. The combined intercept and slope model was determined to be best fitting based 
on AIC to account for time since injury and time of observation per person. 
Mixed effects models were constructed to evaluate the association of initial PTSD 
clinical presentations on estimating pain intensity and interference, separately. Both the 
initial PTSD clinical presentations and the symptom trajectories are treated as fixed-
effects in the models. Sensitivity analyses included generating models after controlling 
for baseline pain intensity and interference. Interaction terms between treatment (RA) and 
time (month since injury) were not significant and did not increase model fits compared 
to those models without interaction terms, based on AIC. Initial BPI measures, or an 
individual’s baseline, were used in sensitivity analyses. Given the difference in the 
spacing of measurements and AIC values, an identity covariance matrix was used to 
account for the model residuals. Model parameters were estimated using maximum 
likelihood with degrees of freedom derived using the Satterthwaite method, after 
comparing against full restricted maximum likelihood estimation (REML) for 
parameters.74,75 A P-value less than .05 was considered significant. All analyses were 
conducted with Stata® 15.0 (Stata Corp SP, College Road, TX, USA). 
Results 
Descriptive Statistics and Baseline Associations 
The sample, at baseline, was predominately young (28.10 years old, +/- 7.00), White 
(76.39%), and almost exclusively male (98.96%) (Table 3-1). In this sample, 149 
participants received RA and 139 participants did not receive RA within two weeks of 




characteristics, except for marital status (P = .032) where the RA cohort had a higher 
percentage who were married (55.70% compared to 41.01%), and an average length of 
hospitalization (P < .001) about 14 days longer (44.10 days compared to 29.90 days). 
There was no significant difference in the proportion of individuals meeting diagnostic 
levels of PTSD at time of entry into the study. Mean PCL-M total symptom severity 
score at baseline was not statistically different between the RA cohorts and the proportion 
of individuals with slope changes worsening, improving, or stable was not significantly 
different between cohorts. The average PCL-M score among individuals with worsening 
PTSD symptom trajectories (30.60 +/- 13.44) was highest compared to those with an 
improving PTSD (26.80 +/- 11.40) symptom trajectory and those with a stable trajectory 
(21.00 +/- 8.61). The  time to entry in study and symptom trajectory interaction term was 
not significant, indicating there was no effect of entry on PTSD symptom severity.  
Longitudinal Associations with Pain Intensity, Interference, and PTSD  
Worst pain and PCL-M score correlation coefficients indicated a moderate positive 
monotonic relationship (rs ≥.51) at several time points within, and at the first 12 months 
after injury (i.e. months 6, 10, 12) and beyond up to 14 months after injury. The 
correlations at these time points were significant (P < .02). A moderate positive 
correlation coefficient between least pain and PCL-M was seen at 6 months (P = .007) 
and again at 13 months (P = .001). There was a high positive correlation (rs ≥.71) 
between, average pain and PCL-M at 6, 13, 16 months that is statistically significant (P < 
.010. Pain right now and PCL-M were statistically significantly associated, with high 




strong association, high positive correlation, was seen between pain interference and 
PCL-M scores exclusively after one year of injury, at months 16, 17, and 18 months (P < 
.05). However, moderate positive correlation coefficients were seen between pain 
interference and PCL-M that were statistically significant across the first two years after 
injury and up to twenty-one months. A statistically significant low to moderate positive 
correlation is seen up to twenty-one months after injury for all pain intensity and 
interference measures, except least pain. These findings are illustrated in Table 3-2. A 
low negative correlation, between all pain outcomes and PCL-M scores, was observed at 
under one month after injury, however this association was not statistically significant. 
Initial Presentations of Pain and PTSD Mixed Effects Models 
A set of models was constructed to evaluate how an individual’s initial PTSD 
presentation was associated with pain intensity and interference, over time in the study 
(Table 3-3). The treatment effect of RA on mean worst pain, least pain, average pain, and 
pain right now was statistically significant, indicating better pain management compared 
to those without RA (β = -.393, P =.001; β = -.263, P < .001; β = -.373, P < .001; β = -
.0274, P = .006, respectively). The treatment effect was not significant for pain 
interference. The time by treatment interaction was not significant and not included in the 
final analysis. Estimates for worst pain, average pain, pain right now, and pain 
interference decrease, with statistical significance, with each month after injury (β = -
.031, P = .001; β = -.028, P < .001; β = -.019, P = .013; β = -.040, P < .001, respectively). 
Length of hospitalization remained statistically significant in estimating worst pain (β = 




.001), with increased length of stays associated with increased patient-reported pain 
outcome estimates, adjusting for all other variables. However, given the small parameter 
estimates, this effect is not clinically meaningful. ISS was not statistically significant in 
the estimates of the association with any pain intensity and interference outcome. 
However, ISS and length of hospitalization were moderately positively correlated 
(Appendix Figure A3-1). Married participants experienced statistically significantly 
higher pain scores for worst pain, pain right now, and pain interference (β = .364, P = 
.001; β = .211, P = .032; β = .499, P < .001, respectively), when compared to the single 
participants. Being a divorced or separated participant was associated with the highest 
pain interference scores, compared to single participants (β = .650, P = .001). Time to 
entry in the study was significant in estimating the association with pain intensity and 
interference. Individuals entering the study after one year of injury were estimated to 
have statistically significantly higher worst pain, least pain, average pain, and pain right 
now (β = 1.010, P = .003; β = .476, P = .020; β = .674, P = .008; β = .629, P = .048, 
respectively).  
Initial PCL-M scores were statistically significant (P < .001) in the model estimating 
the association with all pain outcomes. More symptomatic individuals, or those with 
elevated PCL-M total symptom severity scores, were estimated to have higher BPI pain 
intensity (i.e. worst, least, average, and pain right now) and interference scores. PCL-M 
scores remained statistically significant even after adjusting for initial pain presentations 
in the model. For example, including mean initial average pain scores in the model was 




BPI (β = .545, P < .001). This indicates that elevated pain intensity and interference upon 
entry into the study, across all BPI measures, are associated with higher estimated pain 
outcomes in the future (P < .001). 
PTSD Symptom Trajectory Mixed Effects Models 
Individuals receiving RA experienced less intense worst pain, least pain, average pain 
and pain right now scores than the comparative non-RA cohort at any time point (β = -
.353, P = .002; β = -.253, P < .001; β = -.343, P < .001; β = -.274, P = .006, respectively) 
(Table 3-4). Figures 3-2 to 3-6 illustrate this association between RA receipt and pain 
outcomes. RA was not statistically significantly associated with pain interference.  The 
time by treatment interaction term was not significant and was not included in the 
analysis. Time since injury, measured in months, remained statistically significant in 
models for worst pain, average pain, pain right now, and pain interference, indicating that 
over the course of the study, patient-reported pain intensity and inference decreased (β = -
.030, P < .001; β = -.027, P < .001; β = -.017, P = .031; β = -.037, P < .001, respectively). 
Time since injury was not statistically significant in estimating least pain. Alternatively, 
longer length of hospitalization after initial injury, measured in days, led to small 
incremental, and statistically significant, increases in patient-reported pain outcome 
scores (worst pain, β = .006, P = .010; least pain, β = .002, P = .047; average pain, β = 
.003, P = .037; pain interference, β = .005, P = .002). ISS was not statistically significant 
in any model estimating pain outcomes, indicating that there is no statistical difference in 




Other covariates were found to be associated with pain intensity and interference. 
This includes a participant’s marital status. Being married, or having a partner, was 
associated with participants reporting higher worst pain (β = .331; P = .004), pain right 
now (β = .201; P = .046), and pain interference (β = .456; P < .001), compared to single 
participants. Divorce or separated participants experienced the highest pain interference 
compared to single participants (β = .766; P < .001) Late entry to the study (i.e. more 
than 1 year after injury) was again associated with experiencing higher worst pain 
intensity, but not pain interference (worst pain, β = 1.067; P = .002; least pain, β = .566; 
P = .006; average pain, β = .741; P = .004; pain right now, β = .740). First pain measures 
were associated with the largest coefficients of pain outcomes (worst pain, β = .607; P < 
.001; least pain, β = .577; P < .001; average pain, β = .581; P < .001; pain right now, β = 
.588; P < .001; pain interference, β = .578; P < .001).  
There was a statistically significant difference in the worst pain, average pain, pain 
right now, and pain interference estimates based on PTSD symptom trajectories (Table 
3-4). Worsening PTSD symptoms were associated with higher pain intensity. When 
compared to those with improving PTSD symptom trajectories, individuals with 
worsening PTSD symptom trajectories experienced higher average pain (β = .203, P = 
.018), and pain right now (β = .373, P < .001), controlling for all other covariates and 
accounting for RA status. However, individuals with stable PTSD symptom trajectories 
were estimated to have a statistically significant decrease in their worst pain (β = -.384, P 
= .049), and pain interference (β = -.511, P = .001) compared to those with improving 




pain outcomes. This differential pain response by PTSD symptom trajectory is most 
evident when graphing the marginal linear estimates (Figures 3-7 to 3-11).  
Discussion 
The findings from this analysis identified that initial PTSD symptom severity and PTSD 
symptoms trajectories were associated with statistically significant changes in pain 
intensity and interference. Additionally, combat-injured military personnel and veterans 
receiving RA had lower patient-reported pain outcomes than individuals not receiving 
RA. RA is an effective pain management intervention for controlling pain following 
combat-related injuries.41,50,51,76,77 Findings demonstrate the potential long-term benefits 
of early RA in a combat-injured cohort, seen months after initial RA treatment. This is 
evident by a decrease in all pain intensity measures over time compared to individuals not 
receiving early aggressive multimodal RA. Other investigations have found RA to 
improve the pain experience after combat injury, however, these studies are often limited 
to showing the short-term advantages of RA.3,42,78,79 Often study periods fall short of 
capturing the lasting benefits of early aggressive pain management with RA, as 
accomplished in this study. Other cross-sectional studies of combat-injured service 
members, and prospective studies of shorter duration, clearly support that RA is 
responsible for improvements in pain outcomes.4,51,78 The prospective longitudinal 
investigation of RAMBPOS enables the simultaneous evaluation of the association of 
PTSD symptoms and pain, unlike other investigations of early acute pain management 
which are cross-sectional or retrospective in nature. The ability to observe differences in 




is critically important to justify the sustained value of early RA.  
There is a low to moderate positive correlation between worst pain and PTSD, least 
pain and PTSD, and average pain and PTSD total symptom severity up to twenty-one 
months after injury. Pain interference and PTSD total symptom severity are positively 
correlated at multiple times within one year after injury. However, the strongest 
association between conditions are seen beyond one year after injury. Correlation 
coefficients are similar to shorter year-long investigations of PTSD and pain among 
veterans, which also found symptoms to be significantly moderately correlated.25,33  
In this study, the initial PCL-M score was significantly associated with pain intensity 
and interference. This supports other’s findings that PTSD symptoms are found to be 
significantly associated with higher patient-reported pain after injury.32,33 There is a well-
established relationship between the mutual presentations of PTSD and pain after 
experiencing a combat-related injury.80-82 However, this study differs from previous 
studies examining the presence of these mutual conditions with single items, and instead 
utilizes a validated multi-item patient-reported pain scale, the BPI.25 In RAMBPOS, 
participants with stable PTSD symptom trajectories had the lowest pain intensity, 
followed by those with improving PTSD symptom trajectories, and finally individuals 
with worsening PTSD symptom trajectories experienced the highest pain intensity, 
specifically average pain and pain right now. Both Stratton et al. and Jenewein et al., 
identified that PTSD symptom severity significantly impacted pain intensity in 
participants up to a year after enrollment in their respective studies, but pain did not exert 




demonstrated that pain intensity influences exasperations of specific PTSD 
symptoms.25,32 Conversely, considering Alschuler et al. found that PTSD symptom 
severity may cause variability in pain outcomes, further evaluation of the effects of PTSD 
on pain intensity and interference is warranted.19,84 Additionally, other longitudinal 
investigations between PTSD symptoms and pain are often limited to one year and are 
not specific to OEF/OIF combat-injured American military personnel and 
veterans.25,32,33,83 The average PCL-M scores per PTSD symptom trajectory group in this 
analysis (e.g. stable, worsening, improving), are slightly lower those seen in larger 
cohorts reported by both Bonanno et al.’s and Berntsen et al.’s studies of non-combat 
injured OEF/OIF personnel.38,85  
This secondary analysis investigated the influence of selected covariates in the mixed 
effects model on pain, after receiving RA. Worsening PTSD symptom trajectories, 
marital status, month of observation, prolonged length of hospitalization, entering the 
study more than a year after injury, and initial pain intensity were associated with poorer 
pain outcomes. Consistent with previous findings in the injury literature, pain intensity 
and interference decrease with time.33 Initial pain intensity and interference were 
significant indicators of future pain outcomes, which is comparable to other investigators’ 
findings that initial pain intensity predicts pain up to six and twelve months later.33,86 
Anatomic injury severity was not significant in predicting longitudinal pain intensity or 
interference in the RAMBPOS population, which is consistent with some civilian 
research. 83 However, other authors have questioned the utility of the ISS in accurately 




need for physiologic indicators of injury severity.87 The moderate positive correlation 
between ISS and length of hospitalization could potentially reduce the effect of ISS in the 
final model, despite fitting the data most appropriately. Other factors in our study 
included that married individuals, compared to single combat-injured military personnel 
and veterans, experienced poorer pain intensity. Divorced and separated participants had 
higher pain interference than single participants. Length of hospitalization after injury 
was significant in estimating pain outcomes, and while consistent with other’s findings, 
the effect has little clinical value.88 The small number of individuals entering the study a 
year after injury reported higher pain intensity and interference, compared to those 
enrolled closer to time of injury. While this could introduce sample bias, this small 
number of participants was evenly distributed between RA and No RA cohorts. There 
was no difference between cohorts by age, sex, race, education, or number of 
deployments and were not included in the final analysis. This sample consisted of mostly 
white males and therefore insufficiently powered to detect pain outcomes across racial 
status or sex. A large proportion of participants in the parent study had less than two 
PCL-M observations and were therefore not included in this analysis. The PCL-M was a 
secondary outcome in RAMBPOS that was less frequently collected compared to the BPI 
Advancing current understanding of symptom trajectories will allow scientists and 
clinicians to better plan for the long-term health care requirements of populations with 
serious injuries. Patients, families, and health providers recognize the health needs of 
individuals with serious injuries continue long after acute care.89 Introduced more than 




and chronic pain.40 The synergy created when multimodal regimens are used to target 
discrete components of the peripheral and central pain pathways provides effective 
analgesia at lower opioid dosing, reducing related risk and producing fewer adverse 
effects.90 Advanced training of anesthesiologists and certified registered nurse 
anesthetists in RA is critical to ensuring that optimal pain management approaches are 
available to improved recovery of all injured persons.91  Importantly, advanced pain 
providers do not exist in silos, and combat-injured veterans depend on the support of 
interdisciplinary care providers, including mental health providers.80,92 Given the 
significant role PTSD symptom trajectories were found to have in this analysis, clinicians 
noticing changes in symptom trajectories of PTSD in military personnel and veterans 
during their prolonged rehabilitative care should consider the implications these changes 
have on pain outcomes. Due to the co-occurring nature of these conditions, and the 
potential for individuals to underreport PTSD symptom severity, integrated pain and 
mental health symptom assessments are key to connecting patients to treatment for 
underlying psychological contributions of pain. Systematic observation of symptom 
severities requires that individuals with combat injuries be assessed using standardized 
mental health and pain screenings, including population specific tools such as Pain 
Assessment Screening Tool and Outcomes Registry (PASTOR®) and the Defense and 
Veterans Pain Rating Scale (DVPRS).93,94  
It is important to consider limitations of this research, many of which are common 
with longitudinal observational studies and investigations with recently injured military 




combat-injured participants, there was a high degree of variability as to when participants 
entered the study and how long they remained in the study. For recruitment, every effort 
was made to enroll participants at the time of discharge from acute care at only two 
military hospitals in the US. Extended follow-up of these patients was further 
complicated by the dispersion of subject across the U.S. following discharge. This 
created considerable challenges in finding and following subjects, and thus, patient-
reported outcome data was available for an average of about 7.5 time points for each 
patient, ranging from 2 to 12 observations, and not available on all patients at all time 
points (Appendix Table A3-1). It is hypothesized that the lack of participation was 
predominately driven by the challenges of re-integration and large movement of soldiers 
upon returning to the U.S. One might expect people with fewer problems to be less likely 
to respond so our sample may be biased towards those with more difficult problems. This 
would tend to push results towards the null, and considering there was a difference at all, 
supporting RA was effective on improving pain outcomes, is an indication that the 
difference is more likely to represent the true effect of the treatment. Unlike other 
methods used to assess the relationship between PTSD symptom severity and pain, 
modeling approaches in this analysis are not as sensitive to data missing at random and 
can adjust for disparate data points in the analysis. Mixed effects models utilize all 
available data, while simultaneously adjusting for correlation between an individual’s 
repeated observations even when observations are unequally spaced.72 This modeling 
approach estimates average time trends for entire treatment groups, or in this case RA vs 




Additionally the almost exclusively male sample limits the generalizability of findings to 
female combat-injured military personnel.  
Even with these limitations, the RAMBPOS is one of the most comprehensive 
repeated measures datasets of multivariable patient-reported pain and pain-related 
outcomes to examine the effects of early RA after injury. An individual’s likelihood of 
receiving RA was not randomized given the ethical considerations, but rather based on 
the time of deployment and proximity to a trained RA provider at time of injury in the 
austere combat environment and throughout acute care in a U.S. military healthcare 
facility. Patients with similar injuries may or may not have received RA based on factors 
independent from the study, which should reduce potential selection biases between the 
RA cohorts. PTSD symptom manifestation can take several weeks to months to present 
clinically and therefore the linearity imposed on the PTSD trajectories may not accurately 
capture variability in presentations. Further, this analysis examined total PCL-M total 
symptom severity scores and did not consider the effects of specific PTSD symptoms on 
pain outcomes. RAMBPOS participants’ PTSD total symptom severity was measured 
using the DSM-IV criteria, which has been found to identify similar prevalence rates of 
PTSD as the more recent DSM-5 criteria in OEF/OIF veteran populations.95 All 
individuals in the sample experienced a mild TBI (mTBI), due to their proximity to 
improvised explosive devices and subsequent blast exposure. Moderate and severe TBI 
have been found to influence pain,96 but mTBI alone has not been found to be associated 
with increased pain. While this study examined the effects of PTSD symptom trajectories 




impact of PTSD symptoms on chronic pain, and vice versa.8 Strengths of the current 
study include the ability to account for time since traumatic combat injury to observation 
in order to provide longitudinal estimates of outcomes, and the adjustment for initial 
acute pain management interventions considering the influence this may have on PTSD 
and pain.  
Conclusion 
RA is an effective acute pain management intervention when used as part of an 
interdisciplinary approach to comprehensive trauma care. RA is associated with long-
term benefits in reducing pain intensity after combat injury. PTSD, pain intensity, and 
interference are correlated in the initial months after injury and up to twenty-one months 
after, which suggests that better pain control may help reduce PTSD. There are also 
differential responses in pain intensity and interference based on PTSD symptom 
trajectories. Individuals with worsening PTSD symptom trajectories are estimated to 
experience higher average pain and pain right now following combat injury compared to 
individuals with improving PTSD trajectories. Findings underscore the need for early 
aggressive pain therapy including RA after serious injury. Continued evaluation of both 
pain-related outcomes and PTSD symptoms, have the potential to inform the 






Table 3-1: Sample Characteristics 
  Total No RA RA Test 
Value 
P -
Value   N=288 n=139 n=149 
Agea                
   Mean  28.10 28.30   28.00   
0.39 0.698    Std. dev.  7.00 7.90   6.10   
Sexb               
   Female  1.04% 1.44% 2 0.67% 1 0.41 0.521    Male  98.96% 98.56% 137 99.33% 148 
Raceb                
   White  76.39% 74.82% 104 77.85% 116 
4.54 0.103    Black  4.51% 7.19% 10 2.01% 3 
   Other  19.10% 17.99% 25 20.13% 30 
Ethnicityb               
   Hispanic  12.85% 10.79% 15 14.77% 22 1.01 0.314    Not Hispanic  87.15% 89.21% 124 85.23% 127 
Educationb               
   HS Grad/GED  42.36% 44.60% 62 40.27% 60 
5.49 0.064    Some College  39.58% 43.17% 60 36.24% 54 
   College Grad  18.06% 12.23% 17 23.49% 35 
Marital Statusb               
   Single  45.49% 51.08% 71 40.27% 60 
6.88 0.032    Married/Partnered  48.61% 41.01% 57 55.70% 83 
   Separated/Divorced  5.90% 7.91% 11 4.03% 6 
Number of Deploymentsa               
   Mean  2.00 1.90   2.02   0.38 0.809    Std. dev.  1.09 1.10   1.09   
Length of Stay in 
Hospitala               
   Mean  34.55 29.90   44.10   -3.70 <.001    Std. dev.  30.30 33.10   32.30   
Injury Severity Scorea               
   Mean  17.77 17.72   17.83   -0.09 0.930    Std. dev.  10.13 10.88   9.43   
ISS Categoryb               
   Minor (£9)  21.18% 24.46% 34 18.12% 27 
2.69 0.442    Moderate (10-15) 24.65% 23.02% 32 26.17% 39    Serious (16-24) 34.03% 30.94% 43 36.91% 55 
   Severe (³25) 20.14% 21.58% 30 18.79% 28 
PTSD Diagnosis when 
Entering Studyb   n           
   No 36.37% 74.82% 104 74.50% 111 0.83 0.361    Yes 12.24% 25.18% 35 25.50% 38 
PCL-M Scorea               
   Mean  29.59 29.00   30.12   -0.37 0.711    Std. dev.  14.30 14.00   14.80   
PCL-M Symptom 




Table 3-1: Sample Characteristics 
  Total No RA RA Test 
Value 
P -
Value   N=288 n=139 n=149 
   Improves 49.90% 46.60% 57 0.50 62 
0.20 0.905    Stable 13.40% 11.90% 13 0.12 16 
   Worsens 36.70% 41.50% 69 0.38 71 
Observations Per 
Participant        
   Mean 7.47 7.50  7.44  0.53 0.592    Std. dev. 2.57 2.44  2.71  
Time Since Injury to 
Entering Studyb               
   ≤ 6 Months  76.74% 80.58% 112 73.15% 109 
2.28 0.320    6 Months ≤ 1 Year 15.97% 13.67% 19 18.12% 27 
   > 1 Year  7.29% 5.76% 8 8.72% 13 
PTSD Improving  
(PCL-M Score)a               
   Mean  26.80 26.74   26.80   -0.05 0.961    Std. dev.  11.40 11.61   11.25   
PTSD Stable  
(PCL-M Score)a               
   Mean 21.00 21.06   20.98   
0.05 0.962    Std. dev. 8.61 9.48   7.87   
PTSD Worsening  
(PCL-M Score)a                 
   Mean  30.60 30.69   30.52   
0.11 0.914    Std. dev.  13.44 13.27   13.62   
Worst Pain  
(BPI Score) a                 
   Mean  4.86 5.03   4.71   1.06 0.290    Std. dev.  2.53 2.67   2.41   
Least Pain  
(BPI Score)a                 
   Mean  1.13 1.10   1.14   -0.28 0.783    Std. dev.  1.44 1.40   1.48   
Average Pain  
(BPI Score)a                 
   Mean  2.42 2.57   2.27   1.35 0.179    Std. dev.  2.20 1.86   1.92   
Pain Right Now  
(BPI Score)a                 
   Mean  1.93 1.92   1.93   0.04 0.966    Std. dev.  1.80 1.97   1.80   
Pain Interference  
(BPI Score)a                 
   Mean  1.81 1.89   1.74   0.59 0.555    Std. dev.  1.57 2.32   1.94   
a t-test bchi-square  Coeff.=coefficient; Std. dev=standard deviations; BPI=Brief Pain Inventory; ISS= Injury Severity Score  




Table 3-2: Pain Intensity and PTSD Spearman’s Rank Correlation Coefficients (rs) , by Month Since Injury (N=288) 
Little if any correlation Low positive (negative) correlation Moderate positive (negative) correlation High positive (negative) correlation 
.00 to .30 (.00 to -.30) .31 to.50 (-.31 to -.50) .51 to .70 (-.51 to -.70) .71 to 1.00 ≤ (-.71 to -1.00) 
 
Month 
Worst Pain Least Pain Average Pain Right Now Pain Interference 
Obs. rs 
P 
Value Obs. rs 
P 
Value Obs. rs 
P 
Value Obs. rs 
P 
Value Obs. rs 
P 
Value 
0 8 -0.43 0.288 10 -0.16 0.655 10 -0.13 0.719 10 -0.33 0.351 10 -0.01 0.987 
1 66 0.37 0.002 77 0.33 0.003 77 0.40 <0.001 77 0.32 0.004 76 0.43 <0.001 
2 57 0.12 0.383 63 0.11 0.374 63 0.19 0.127 63 0.21 0.1 59 0.43 <0.001 
3 30 0.40 0.027 36 0.22 0.193 36 0.43 0.009 36 0.26 0.1 34 0.53 0.001 
4 22 0.30 0.181 28 0.33 0.082 28 0.43 0.023 28 0.55 0.003 24 0.63 0.001 
5 19 0.26 0.291 20 -0.03 0.885 20 0.02 0.949 20 0.09 0.694 19 0.23 0.347 
6 17 0.54 0.026 20 0.58 0.007 20 0.71 <0.001 20 0.74 <0.001 18 0.67 0.002 
7 27 0.30 0.135 34 0.37 0.030 34 0.53 0.001 34 0.41 0.015 28 0.41 0.033 
8 107 0.32 <0.001 127 0.21 0.016 127 0.38 <0.001 127 0.29 <0.001 111 0.47 <0.001 
9 24 0.40 0.050 27 0.46 0.017 27 0.49 0.009 27 0.37 0.055 25 0.57 0.003 
10 13 0.64 0.019 14 0.01 0.386 14 0.58 0.029 14 0.27 0.347 14 0.62 0.019 
11 7 0.70 0.062 10 0.39 0.270 10 0.35 0.324 10 0.19 0.593 7 0.51 0.243 
12 20 0.66 0.002 25 0.43 0.033 25 0.42 0.035 25 0.46 0.022 21 0.60 0.001 
13 22 0.45 0.034 30 0.58 0.001 30 0.73 <0.001 30 0.71 <0.001 24 0.60 0.002 
14 90 0.52 <0.001 104 0.45 <0.001 104 0.48 <.0001 104 0.47 <0.001 92 0.55 <0.001 
15 26 0.20 0.323 30 0.45 0.013 30 0.48 0.008 30 0.40 0.028 28 0.66 0.001 
16 10 0.48 0.159 10 0.60 0.679 10 0.79 0.006 10 0.75 0.013 10 0.86 0.001 
17 10 0.58 0.076 10 0.33 0.359 10 0.60 0.066 10 0.54 0.108 10 0.75 0.013 
18 14 0.53 0.529 15 0.39 0.156 15 0.55 0.035 15 0.69 0.004 14 0.76 0.001 
19 22 0.34 0.119 26 0.25 0.224 26 0.49 0.011 26 0.42 0.033 22 0.62 0.002 
20 71 0.32 0.007 80 0.40 <0.001 80 0.39 <0.001 80 0.47 <0.001 73 0.60 <0.001 
21 27 0.44 0.021 33 0.34 0.051 33 0.57 <0.001 33 0.51 0.003 29 0.63 <0.001 
22 9 -0.17 0.654 12 0.37 0.242 12 0.50 0.099 12 0.33 0.288 10 0.03 0.981 
23 4 0.32 0.684 7 0.14 0.757 7 0.16 0.739 7 0.31 0.499 4 0.60 0.400 





Table 3-3: Initial Presentations of Pain and PTSD (N=288) 
 Worst Pain Least Pain 
 Coef. LCI UCI P - Value Coef. LCI UCI P - Value 
Intercept 1.721 1.317 2.125 < .001 0.039 -0.180 0.258 0.728 
Regional Anesthesia          
  No - - - - - - - - 
  Yes -0.393 -0.621 -0.165 0.001 -0.263 -0.396 -0.129 < .001 
Month Since Injury (0-24) -0.031 -0.048 -0.015 < .001 0.001 -0.008 0.011 0.781 
Initial PTSD Checklist Score (17-85) 0.020 0.011 0.030 < .001 0.016 0.010 0.022 < .001 
Injury Severity Score         
  Minor [Reference]  - - - - - - - - 
  Moderate -0.060 -0.363 0.244 0.700 0.130 -0.048 0.308 0.153 
  Serious -0.060 -0.365 0.246 0.702 -0.013 -0.191 0.166 0.891 
  Severe 0.071 -0.287 0.429 0.698 0.041 -0.168 0.249 0.701 
Length of Hospitalization (Days) 0.006 0.002 0.010 0.007 0.002 0.000 0.005 0.059 
Marital Status         
  Single [Reference] - - - - - - - - 
  Married/Partnered  0.364 0.140 0.588 0.001 0.059 -0.072 0.189 0.378 
  Separated/Divorced 0.249 -0.218 0.717 0.296 -0.183 -0.455 0.090 0.189 
Entry Cohort         
   ≤ 6 Months [Reference] - - - - - - - - 
   6 Months ≤ 1 Year -0.129 -0.526 0.268 0.524 -0.039 -0.273 0.195 0.745 
   > 1 Year  1.010 0.335 1.685 0.003 0.476 0.075 0.876 0.020 
First Pain Measure 0.577 0.530 0.624 < .001 0.538 0.492 0.585 < .001 
Coeff = coefficient; UCI = upper 95% confidence interval; LCI = lower 95% confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial 







Table 3-3 (continued) 
	 Average Pain Pain Right Now Pain Interference 
	 Coef. LCI UCI P - Value Coef. LCI UCI 
P - 
Value Coef. LCI UCI 
P - 
Value 
Intercept 0.864 0.584 1.144 < .001 0.129 -0.187 0.445 0.425 -0.160 -0.461 0.141 0.298 
Regional Anesthesia              
  No - - - - - - - - - - - - 
  Yes -0.373 -0.541 -0.205 < .001 -0.274 -0.468 -0.080 0.006 -0.056 -0.237 0.126 0.549 
Month Since Injury (0-24) -0.028 -0.040 -0.016 < .001 -0.019 -0.034 -0.004 0.013 -0.040 -0.053 -0.027 < .001 
Initial PTSD Checklist Score (17-
85) 0.020 0.013 0.027 < .001 0.027 0.019 0.035 < .001 0.039 0.031 0.047 < .001 
Injury Severity Score             
  Minor [Reference]  - - - - - - - - - - - - 
  Moderate -0.079 -0.302 0.145 0.491 -0.168 -0.425 0.089 0.199 0.133 -0.109 0.375 0.281 
  Serious -0.059 -0.284 0.166 0.608 -0.037 -0.295 0.221 0.778 -0.049 -0.292 0.194 0.693 
  Severe -0.066 -0.328 0.197 0.624 -0.219 -0.522 0.084 0.157 0.076 -0.209 0.360 0.601 
Length of Hospitalization (Days) 0.003 0.000 0.006 0.037 0.003 -0.001 0.006 0.140 0.006 0.002 0.009 0.001 
Marital Status             
  Single [Reference] - - - - - - - - - - - - 
  Married/Partnered  0.158 -0.009 0.324 0.064 0.211 0.019 0.404 0.032 0.499 0.321 0.677 < .001 
  Separated/Divorced 0.060 -0.283 0.403 0.731 -0.039 -0.433 0.356 0.847 0.650 0.279 1.022 0.001 
Entry Cohort             
   ≤ 6 Months [Reference] - - - - - - - - - - - - 
   6 Months ≤ 1 Year 0.143 -0.151 0.436 0.340 0.252 -0.111 0.616 0.174 0.025 -0.289 0.338 0.877 
   > 1 Year  0.674 0.176 1.172 0.008 0.629 0.005 1.253 0.048 0.518 -0.015 1.050 0.057 
First Pain Measure 0.545 0.498 0.593 < .001 0.556 0.509 0.603 < .001 0.485 0.443 0.527 < .001 
Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain 




Table 3-4: Mixed Effects Model with PTSD Trajectory (N=288) 
 
Worst Pain Least Pain 
Coef. LCI UCI P - Value Coef. LCI UCI P - Value 
Intercept 2.172 1.797 2.548 < .001 0.344 0.152 0.535 < .001 
Regional Anesthesia          
  No [Reference] - - - - - - - - 
  Yes -0.353 -0.582 -0.125 0.002 -0.253 -0.387 -0.119 < .001 
Month Since Injury (0-24) -0.030 -0.047 -0.014 < .001 0.002 -0.008 0.012 0.663 
Change in PTSD Slope         
  Improving (¯) [Reference] - - - - - - - - 
  Stable («) -0.384 -0.767 -0.002 0.049 0.039 -0.187 0.264 0.736 
  Worsening (­) -0.039 -0.273 0.195 0.746 0.113 -0.022 0.247 0.100 
Injury Severity          
  Minor [Reference]  - - - - - - - - 
  Moderate -0.034 -0.338 0.270 0.825 0.162 -0.017 0.341 0.077 
  Serious -0.042 -0.348 0.263 0.786 -0.004 -0.183 0.176 0.968 
  Severe 0.032 -0.328 0.392 0.860 0.005 -0.205 0.216 0.961 
Length of Hospitalization 
(Days) 0.006 0.001 0.010 0.010 0.002 0.000 0.005 0.047 
Marital Status         
  Single [Reference] - - - - - - - - 
  Married/Partnered  0.331 0.104 0.559 0.004 0.059 -0.075 0.192 0.388 
  Separated/Divorced 0.321 -0.148 0.790 0.180 -0.145 -0.420 0.130 0.302 
Entry Cohort         
   ≤ 6 Months [Reference] - - - - - - - - 
   6 Months ≤ 1 Year -0.099 -0.495 0.296 0.623 -0.012 -0.246 0.223 0.923 
   > 1 Year  1.067 0.387 1.746 0.002 0.566 0.162 0.971 0.006 
First Pain Measure 0.607 0.560 0.654 < .001 0.577 0.533 0.622 < .001 
 
Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain 




Table 3-4 (continued) 
Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial pain 
presentation score= the same, initial BPI score corresponding to the outcome measure
 
Average Pain Pain Right Now Interference 
Coef. LCI UCI P-Value Coef. LCI UCI P-Value Coef. LCI UCI P-Value 
Intercept 1.230 0.977 1.483 < .001 0.582 0.308 0.857 < .001 0.790 0.525 1.054 < .001 
Regional Anesthesia              
  No [Reference] - - - - - - - - - - - - 
  Yes -0.343 -0.511 -0.175 < .001 -0.274 -0.471 -0.078 0.006 0.037 -0.149 0.224 0.694 
Month Since Injury  
(0-24) -0.027 -0.039 -0.015 < .001 -0.017 -0.032 -0.002 0.031 -0.037 -0.051 -0.024 < .001 
Change in PTSD Slope             
  Improving (¯)    
  [Reference] - - - - - - - - - - - - 
  Stable («) -0.192 -0.474 0.089 0.180 0.145 -0.187 0.476 0.393 -0.511 -0.822 -0.200 0.001 
  Worsening (­) 0.203 0.034 0.371 0.018 0.373 0.180 0.567 < .001 -0.064 -0.252 0.124 0.504 
Injury Severity              
  Minor [Reference]  - - - - - - - - - - - - 
  Moderate -0.045 -0.269 0.178 0.690 -0.130 -0.390 0.129 0.324 0.148 -0.099 0.396 0.241 
  Serious -0.049 -0.274 0.175 0.666 -0.028 -0.288 0.232 0.833 -0.054 -0.302 0.194 0.670 
  Severe -0.125 -0.388 0.138 0.350 -0.303 -0.608 0.003 0.052 -0.064 -0.355 0.227 0.667 
Length of 
Hospitalization (Days) 0.003 0.000 0.006 0.037 0.003 -0.001 0.007 0.134 0.005 0.002 0.009 0.002 
Marital Status             
  Single [Reference] - - - - - - - - - - - - 
  Married/Partnered  0.116 -0.053 0.285 0.179 0.201 0.004 0.398 0.046 0.456 0.271 0.641 < .001 
  Separated/Divorced 0.089 -0.255 0.433 0.612 -0.007 -0.406 0.392 0.972 0.766 0.385 1.147 < .001 
Entry Cohort             
   ≤ 6 Months [Reference] - - - - - - - - - - - - 
   6 Months ≤ 1 Year 0.191 -0.100 0.482 0.198 0.307 -0.057 0.672 0.099 0.099 -0.221 0.419 0.544 
   > 1 Year  0.741 0.241 1.240 0.004 0.740 0.106 1.375 0.022 0.547 -0.004 1.097 0.052 




Figure 3-1: PTSD Symptom Trajectories based on PCL-M Slope, examples 
 







PCL-M Score Slope Indicator Term 
PTSD Gets Worse 30 17 Positive (+) Worsening PTSD 
PTSD Remains 
Stagnant 20 20 Zero (0) Stable PTSD 




Figure 3-2: Worst Pain by RA receipt  
 
 






Figure 3-4: Average Pain by RA receipt  
 
 












Figure 3-7: Worst Pain by PTSD Symptom Trajectory  
 
 






Figure 3-9: Average Pain by PTSD Symptom Trajectory  
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2 26 9.03 
3 32 11.11 
4 35 12.15 
5 26 9.03 
6 35 12.15 
7 35 12.15 
8 28 9.72 
9 23 7.99 
10 32 11.11 
11 10 3.47 
12 6 2.08 
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Table A3-2 Sensitivity Analysis with Adjusted PTSD Trajectory Caliber  
  
Worst Pain Least Pain Average Pain Pain Right Now  Pain Interference 
Coef LCI UCI P  Coef LCI UCI P Coef LCI UCI P  Coef LCI UCI P  Coef LCI UCI P  
Intercept 1.88 1.49 2.27 0.00 0.40 0.21 0.58 0.00 1.16 0.90 1.41 0.00 0.53 0.27 0.80 0.00 1.05 0.76 1.33 0.00 
Regional Anesthesia                      
  No [Reference] - - - - - - - - - - - - - - - - - - - - 
  Yes -0.15 -0.40 0.10 0.23 -0.21 -0.34 -0.08 0.00 -0.24 -0.41 -0.07 0.01 -0.15 -0.34 0.04 0.11 0.02 -0.17 0.22 0.83 
Month Since Injury 
(0-24) -0.04 -0.06 -0.03 0.00 0.00 -0.01 0.01 0.50 -0.03 -0.04 -0.02 0.00 -0.01 -0.03 0.00 0.04 -0.04 -0.05 -0.02 0.00 
Change in PTSD 
Slope                     
  Improving (¯)    
  [Reference] [n=628] - - - - - - - - - - - - - - - - - - - - 
  Stable («) [n=636] -0.28 -0.57 0.01 0.06 -0.06 -0.21 0.10 0.48 -0.23 -0.43 -0.03 0.02 -0.06 -0.28 0.16 0.62 -0.52 -0.76 -0.29 0.00 
  Worsening (­)    
  [n=645] 
0.06 -0.23 0.36 0.68 0.17 0.02 0.31 0.03 0.31 0.11 0.51 0.00 0.44 0.22 0.65 0.00 -0.14 -0.36 0.09 0.23 
Injury Severity 




0.01 0.01 0.01 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.01 0.03 0.01 0.00 0.01 0.00 
Marital Status                     
  Single [Reference] - - - - - - - - - - - - - - - - - - - - 
  Married/Partnered  0.43 0.19 0.68 0.00 0.05 -0.07 0.18 0.43 0.21 0.04 0.37 0.02 0.14 -0.04 0.33 0.14 0.52 0.33 0.71 0.00 
  Separated/Divorced 0.11 -0.43 0.65 0.70 -0.01 -0.28 0.27 0.96 -0.02 -0.39 0.35 0.92 -0.05 -0.45 0.36 0.83 0.55 0.14 0.96 0.01 
Entry Cohort                     
   ≤ 6 Months    
  [Reference] - - - - - - - - - - - - - - - - - - - - 
   6 Months ≤ 1 Year -0.23 -0.68 0.23 0.33 -0.06 -0.29 0.18 0.64 0.08 -0.22 0.39 0.60 0.38 0.02 0.74 0.04 -0.13 -0.47 0.22 0.47 
   > 1 Year  1.04 0.28 1.80 0.01 0.60 0.21 0.99 0.00 0.72 0.21 1.23 0.01 0.79 0.18 1.40 0.01 0.41 -0.17 0.99 0.17 
First Pain Measure 0.59 0.54 0.63 0.00 0.56 0.51 0.60 0.00 0.55 0.50 0.59 0.00 0.59 0.54 0.63 0.00 0.54 0.50 0.59 0.00 
Coeff = coefficient; UCI = upper confidence interval; LCI = lower confidence interval; RA = regional anesthesia; P=P-value; BPI = brief pain inventory; PTSD = post-traumatic stress disorder; Initial 
pain presentation score= the same, initial BPI score corresponding to the outcome measure 
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Figure A3-1:  PTSD Checklist Scores and Worst Pain, by Month of Observation 
 







Figure A3-3: PTSD Checklist Scores and Average Pain, by Month of Observation 
 
 

















Utilizing Markov Models to Illustrate Pain Transitions After Combat Injury 
Abstract  
Few longitudinal investigations of combat-injured American military personnel and 
veterans examine the effects of acute pain management on long-term patient-reported 
pain outcomes. Markov models are mathematical models that can be used to simulate 
disease process in a series of states, such as describing how patients are likely to 
transition from one pain state to another, in a probabilistic fashion. Utilizing data from 
355 combat-injured military personnel, this modeling study characterized probabilistic 
pain trajectories, stratified by either receipt of regional anesthesia (RA) or systemic pain 
management after injury, across multiple dimensions of pain intensity (e.g. worst, 
average, and pain right now). Findings show that individuals are likely to transition out of 
states of severe and moderate pain to states of lower pain intensity or no pain. Transition 
probabilities ranged from <1.00% from no pain to severe pain, to 75.00% for the 
transition from a state of no pain to remaining in a state of no pain. While simulated 
projections indicate differences in the probability of remaining in a state of severe or 
moderate pain up to 24 months after injury by pain management intervention, there is no 
statistically significant difference between the distributions by regional anesthesia (RA) 
and standard systemic pain management approaches (worst pain, AD=0.2576, P=0.13; 
average pain, AD=0.2348, P=0.21; pain right now, AD=0.1853, P=.82). Results indicate 
that Markov modeling is a practical approach for describing probabilistic combat injury 






Advancements in prehospital combat casualty care have contributed to reducing 
preventable deaths on the battlefield,1 but have resulted in soldiers surviving with more 
severe disabilities and significant problems with chronic pain. Yet, there is a dearth of 
evidence regarding the long-term benefits of early pain management for survivors. 
Ongoing pain assessment and management from the point of injury and throughout the 
care continuum are thought to be key to mitigating risks for developing chronic pain.2 
Despite resolution of the initial injury, maladaptive biopsychosocial mechanisms can 
manifest in chronic pain, defined as persistent pain lasting over three months.3  Rates of 
chronic pain in the United States (U.S.) Operation Enduring Freedom and Operation Iraqi 
Freedom (OEF/OIF) care-seeking veteran population are estimated to be 28% to 47%,4  
and up to 83% among polytrauma survivors (i.e. those with multiple affected body 
regions and organ systems).5 Chronic pain experienced by veterans is associated with 
lower physical function,6 increased risk of comorbid mental health conditions (e.g. post-
traumatic stress disorder [PTSD]),7 increased healthcare utilization,8 and poorer quality of 
life.9  The administration of multimodal analgesics in prehospital care and prior to 
surgery is believed to reduce both peripheral and central sensitization caused by injury, 
thereby lessening the onset of pain windup, a pathological process contributing to the 
transition of acute to chronic pain.10-13  
Timely and targeted delivery of pharmacotherapy in the aftermath of combat injury 
has a demonstrated ability to reduce acute pain intensity.14 Yet, widespread patient 
dissatisfaction with pain control after combat injury suggests acute pain management 




management of acute pain is essential to minimize the risk of developing chronic pain 
after combat injury. The administration of systemic analgesics during trauma care has 
been found to alleviate acute pain in a timely manner and even reduce the risk of 
developing mental health conditions.15-17 However, these systemic approaches increase 
risks for over sedation, respiratory depression, and vasodilation leading to hypotension 
and additional blood loss,18 which can be life-threatening adverse events.  
Analgesics and anesthetics delivered through a peripheral nerve block or epidural, 
known as regional anesthesia (RA), have been shown to provide a more optimal 
management of acute pain at the point of combat injury and throughout acute care in U.S. 
military medical facilities.12,13,16,19,20 RA’s targeted delivery of multimodal analgesics has 
lower risk of hypotension and hypoventilation than that seen in systemic medication 
administration.18 Implementation of acute pain services, access to RA trained pain 
providers in combat support hospitals, and adherence to pain management guidelines 
have been shown to improve pain monitoring and relief after combat injury.11,16,21 Yet, 
research designs examining the effects of acute pain management, specifically RA, in the 
immediate aftermath of combat injury, transportation, and the intraoperative periods, are 
generally cross-sectional, retrospective, or of limited duration, with many primarily 
conducted in the acute phase of recovery.12,13,16,19,20 Evaluation of the long-term effects of 
acute pain management is complicated due to the limited pain interventions available in 
the austere environment, suboptimal recording of pain assessment and treatment 
documentation throughout care, and challenges engaging survivors in research during 
community reintegration.2,11,21 Given the complexities in studying outcomes after combat 




completed Regional Anesthesia Military Battlefield Pain Outcomes Study (RAMBPOS) 
collected data at multiple time points over the duration of 2 years after combat-related 
injury and examined the effect of early acute pain management interventions after injury. 
RAMBPOS participants provided patient-reported outcomes throughout recovery, 
including measures of multiple presentations, or dimensions, of their pain experience. 
The multiple dimensions include worst pain, least pain, average pain, and pain right now 
at time of assessment. 
Markov models are mathematical models that can be used to simulate disease process 
that can be shown as a series of states, and pain trajectories happen to be such a process. 
Markov modeling simulates randomly changing systems, or disease states, where the 
future state is independent of the past and only dependent on the current state. This 
modeling approach can provide insight into disease or condition specific behavior 
represented based on a set of transitions. Markov models can be used to leverage 
currently available pain intensity data sources, such as RAMBPOS, in order to generate 
parameter estimates from which to draw samples of pain trajectories from large 
theoretical combat-injured cohorts. Markov models are used extensively in cost-
effectiveness analyses to longitudinally project the benefits of pain interventions.22 The 
key assumption of a Markov model is that transitions between states form a Markov 
chain. As such, transitions to future states are dependent only on the current state and not 
on any previous states. Markov chains represent repetitive events and time, such as 
changes in pain intensity, using probabilities of future transitions. Tighe et al. 
demonstrated the application of using Markov chains in illustrating acute pain transitions, 




from 0 to 10.23 Additionally, Markov chains have been used to estimate long-term 
differences in the cost of care for British military amputees after being injured in 
Afghanistan.24 To our knowledge, no investigation has evaluated the effects of RA on 
long-term pain trajectories after combat injury. The Markov chain approach enables the 
computation of pain trajectories in a probabilistic manner, while also adjusting for acute 
pain management interventions and time. The aims of this study are to 1) define 
probabilities of pain trajectories after combat injury across multiple dimensions of pain 
intensity, 2) stratify pain trajectories by RA receipt, and 3) estimate pain trajectories from 
high pain intensity to low pain intensity. The benefit of this approach is that simulations 
with Markov models can form the foundation of decision models that incorporate care 
decisions and clinical outcomes, such as quality of life and costs in the future. 
Methods 
This modeling study utilized RAMBPOS participants’ data to estimate transition 
probabilities. IRB approval for this study was provided by the Veteran’s Affairs Office of 
Research and Development and the University of Pennsylvania.  
Description of Data 
RAMBPOS is a prospective observational cohort study of U.S. OEF/OIF military 
personnel with major combat-related limb injuries and known receipt status to early 
aggressive RA. By collecting patient-reported outcomes over the first two years after 
combat injury, RAMBPOS provides one of the most comprehensive examinations of the 
short- and long-term benefits of implementing early RA for pain control after major 
traumatic limb injuries. Depending on the date and geographic location of injury, 




support hospital in a forward operating base with a trained military RA provider deployed 
at the time, or (2) based the availability of RA providers and acute pain services upon 
arrival in a U.S. military hospital. Individuals receiving RA within two weeks after injury 
in either of these conditions are part of the RA cohort. The No RA cohort consists of 
participants who did not receive early RA within two months of injury. The No RA 
cohort received standard systemic multimodal pain management throughout 
transportation and acute care at U.S. military medical facilities.  
The RAMBPOS dataset includes patient demographics, injury characteristics, RA 
treatment and patient-reported pain outcomes. Participants were recruited and consented 
during acute care and rehabilitation at two military medical facilities in the continental 
U.S. Any military personnel with a combat-related major injury involving one or more 
extremities and requiring hospitalization was eligible for enrollment. Eligible individuals 
with cognitive deficits, moderate and severe traumatic brain injury (TBI), inability to 
concentrate, poor judgment and impulse control, substantial hearing loss, and bilateral 
upper extremity amputation with no alternate means to complete the survey forms were 
excluded. After eligibility screening and consent, individuals could enter the study at any 
time within the first two years after injury. Between October 2007 and September 2014, a 
total of 386 individuals were enrolled. Medical records in the Department of Defense 
(DOD) Trauma Registry, provided clinical and military career information, including 
injury characteristics, sociodemographic information, and RA receipt status. Patient-
reported outcomes, including the Brief Pain Inventory (BPI), were collected monthly 




combat injury. Only participants with two or more complete BPI observations were 
included in this analysis, for a total of 355 eligible participants.  
The Brief Pain Inventory (BPI) is a 9-item pain assessment tool measuring pain 
intensity and interference.25,26 The BPI measures the multidimensional nature of pain 
intensity, specifically worst pain, average pain, and pain right now. Worst pain refers to 
the most intense pain experienced in the past 24 hours, measured from 0, “no pain” 10, 
“pain as bad as you can imagine.” The BPI average pain measure is an individual’s 
reflection of the routine pain they experienced in the past 24 hours, whereas pain right 
now refers to pain experienced at time of assessment using the same 0 to 10 scale. 
Leading experts from the Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials (IMMPACT) panel recommended that all measures of pain intensity, 
rather than just current pain, be included as outcomes in chronic-pain clinical trials.27 The 
BPI was chosen for the analysis because of its brevity, its capability to capture multiple 
dimensions of pain intensity, and its frequency of administration in the parent study. For 
each BPI pain intensity score, the time since injury (measured in months) was calculated 
to create a common reference point. Using 3-subscales of the BPI (worst pain, average 
pain, and pain right now), we defined 4 pain states: no pain, mild pain, moderate pain, 
and severe pain (Figure 4-1). These states correspond to established pain intensity 
classifications from BPI scores: none (0), mild (1-4), moderate (5-6), and severe (7-10).28 
This categorization by pain intensity rating was compared to an expanded multiple 
objective state categorization utilizing the 0 to 10 BPI responses. The utility of the 
expanded form in long-term clinical care and medical decision-making is questionable, 




Pain state is defined by an individuals’ BPI pain intensity (e.g., average, worst, and pain 
right now) scores at any given month after injury. The transition from one pain state to 
another (even if remaining in a specific state) over time, refers to individuals’ changes in 
BPI pain intensity scores. These transitions, when examined over time, are considered the 
pain trajectory. Individuals can only be in one pain state, over one discrete time period, 
per trajectory. However, across pain trajectories individuals can be in different pain states 
(e.g. in severe worst pain at one month and in mild average pain during that same month). 
The RAMBPOS’ BPI data were used to obtain the probability of transitioning between 
each pain state for patients receiving RA compared to No RA. In total, three pain 
trajectories were constructed and then stratified by RA receipt status. The BPI measure 
for least pain was excluded from the modeling after assessing distribution was almost 
exclusively a score of 0 or 1.  
Defining the Markov Chains and Transition Matrices   
Markov models are mathematical predictions of recursive decision trees that are used to 
model conditions with events that may occur repeatedly over time, such as pain intensity. 
Markov models explicitly account for the passing of time, in the case of this analysis each 
month since injury, and values of pain intensity at designated time points throughout the 
study. Pain intensity values are discrete and measurements occur at regular intervals 
which is a criterion for modeling as a stochastic process, using Markov chains. In terms 
of Markov chains, future transitions are based on the present state of an individual and 
are independent of past transitions or states.29 An individual’s history of BPI score 




Collectively, the pain states and their associated probabilities in Markov chains are 
presented as a transition matrix.  
The transition matrix provides insight as to how combat-injured individuals move 
across pain states in a probabilistic manner. In the transition matrix, the rows represent 
the current state of the individual, and the columns represent future states. Using a long 
file, with separate records for each repeated measure by a RAMBPOS participant, 
individuals’ monthly movements from one pain state to another were counted using an 
algorithm. Probability parameters were derived by summing the total transition count (the 
number of time transitions) from one pain state (row) to an another (column), all divided 
over the sum of the row’s count. One of the goals of acute pain management is to move 
patients from a state of high pain intensity to a state of lower intensity. A prolonged 
length of stay, up to three months, in a state of high pain intensity (moderate or severe) 
were considered chronic pain for the purpose of this analysis. Transitions were modeled 
in monthly increments. The Markov chain allows for the evaluation of movement across 
states in a series of steps by multiplying the probability of moving from a row specified 
state by the probability of a column state raised to the number of months. Stationary 
distributions derived from the Markov chain probabilities allow for side by side 
comparison between stratified groups, such as RA and No RA. Similarly, the number of 
transitions needed, or time in which individuals move from high pain intensity to low 
pain intensity states can be compared.  
Results 
Overall, RAMBPOS participants were young (28.00 years old, [Standard Deviation] +/-




severity was measured using the Injury Severity Score (ISS), a numeric rating scale 
where 75 indicates the greatest severity and death, and 0 is equal to no injury. More than 
half the sample experienced serious (32.6%) or severe injuries (22.70%), with an average 
injury severity score of 18.40 (+/- 10.8). Length of acute hospitalization was about 37 
days, on average (+/- 33.4). The average number of deployments in this sample was 2 
(+/- 1.3). In this subsample, 185 participants received RA, and 170 did not, known as the 
No RA group. Three quarters of participants entered the RAMBPOS ≤ 6 months after 
injury (75.80%). Table 4-2 provides sample characteristics of the RAMBPOS 
participant’s pain transition data used for this analysis. In total, 2,214 pain observations 
provided from 355 participants were used to calculate transition probabilities. About half 
of the observations were from participants who had received RA (51.90%) and the other 
half from those who did not receive RA (48.10%).  
Overview of the Transition Matrices  
The value of condensing pain states from 11 discrete states (0 to 10), to 4 (none, mild, 
moderate, severe) is that movement across states requires larger incremental changes in 
pain intensity and is not as sensitive to small, and less clinically meaningful, changes. 
The condensed states, using worst pain as an example, provides an observable trend in 
transition probabilities. The worst pain transition matrix is positive recurrent and 
irreducible with no absorbing state. Individuals can transition from any pain state to 
another, with a probability as low as 1.00% and as high as 65.00% (Figure 4-2). The 
strongest probabilities are individuals transitioning from their current state and remaining 
there, with a probability of 49.00% to 65.00% (i.e. the diagonal of the table). However, in 




with probabilities from 0.00% to 8.0% (Figure 4-3). Similarly, individuals in severe pain 
right now infrequently remain in a state of severe pain (probabilities 0.00% to 16.00%). 
In the pain right now matrix, individuals have a higher probability to quickly transition 
from severe to moderate pain states (43.00%) and from moderate to mild pain states 
(59.00%). This indicates individuals gravitate towards lower pain states when reporting 
pain right now.  
Characterization of Stationary Distributions by RA 
Transition matrices for worst pain, average pain, and pain right now were stratified by 
intervention status (RA vs. No RA). Initial distributions across pain states by RA status 
are displayed Table 4-3. Initial distributions are provided by the RAMBPOS cohorts and 
their clinical pain presentations in the study. Figure 4-4 compares the stationary 
distribution for worst pain by RA and No RA. There was no statistically significant 
difference in the distributions by intervention (Anderson-Darling [AD] = 0.2576, P = 
0.13). Based on the initial distribution provided by the RAMBPOS, after two years, or 24 
monthly transitions, there is a 18.60% probability that individuals who did not receive 
early RA will be in state of no pain, 28.90% in a state mild pain, 38.00% in moderate 
pain, and 14.5% severe pain. Alternatively, there is only a 10.10% probability for those 
who receive early RA to be in a state of no pain, 30.60% in a state in mild pain, 45.40% 
in moderate pain, and 13.90% in severe pain (Figure 4-5).  
The distributions were not statistically different by RA status, both for average pain 
and pain right now (AD = 0.238, P = 0.21; AD = 0.1853, P > 0.82, respectively). Based 
on the transition matrix for average pain (Figure 4-6) individuals receiving RA have a 




moderate pain, and only 0.60% in severe pain up to 2 years after injury. Overall, 
individuals who do not receive RA have a probability of 28.70% to be in no pain, 47.80% 
in mild pain, 23.20% in moderate pain, and 0.39% in severe pain (Figure 4-7). The 
transition matrices for pain right now (Figure 4-8) indicate a probability of 35.30% in no 
pain, 55.00% in mild pain, 8.70% in moderate pain, and only 1.00% in severe pain at 24 
months post-injury and after receiving RA after 24 months (Figure 4-9). Alternatively, a 
larger probability exists for individuals not receiving RA to be in no pain right now, 
44.80%, but also a slightly larger probability to be in severe pain, 2.30%. At 2 years after 
injury individuals without RA have a 46.90% probability of being in mild pain right now 
and 6.00% in moderate pain right now.  
The most prominent transition occurs within the first 6 months after injury and 
provides an opportunity to examine the movement from severe acute pain to no pain 
(Figures 4-10, 4-11, 4-12). For example, if all combat-injured individuals (100% of a 
given sample) are assumed to be in severe average pain within the first month after 
injury, there is a 58.70% probability that combat-injured persons receiving RA are 
estimated to transition to mild or no pain within 3 months. Whereas, only a 52.70% 
probability for individuals not receiving RA to be in average mild or no pain in that same 
transition time of 3 months. This translates to less than a quarter (23.90%) of RA 
recipients being in chronic moderate or severe average pain at 6 months, compared to a 
third (30.70%) of individuals who did not receive RA. This projection can continue out to 
24 months, for participants who did receive RA the probability of remaining in chronic 
moderate or severe pain is less than a fifth (19.00%) as opposed to a 23.00% probability 




transitioning out of severe or moderate pain faster does not hold for pain right now. A 
higher proportion of individuals who received RA remain in chronic moderate or severe 
pain at 3 months (18.40%, RA; 15.70%, No RA), 6 months (11.50% RA; 9.60% No RA), 
or 24 months (10.80% RA; 8.30% No RA). There is a slightly smaller estimated 
probability for RA recipients to experience moderate or severe worst pain (72.40%) than 
those without early aggressive RA (73.30%) in the first 3 months after injury. Yet, there 
is a higher probability for individuals receiving early RA to experience moderate or 
severe worst pain at 6 months (62.20%) and 24 months (59.30%) in comparison to the No 
RA cohort (59.90%, 6 months; 52.50%, 24 months). 
Discussion  
The findings of this study demonstrate how individuals move across pain states after 
combat injury using Markov chains to visualize the transition from moderate and severe 
acute pain to moderate and severe chronic pain. Early pain trajectories, in the initial 
months after injury, have the potential to inform researchers and providers of individuals 
likely to develop future chronic severe or moderate pain.30 These trajectories can inform 
the proactive and timely delivery of acute pain management interventions that not only 
control pain but also prevent long-term moderate or severe chronic pain from developing. 
Modeling symptom trajectories and responses to management interventions can inform 
the design of future pragmatic trials that utilize successful interventions. The utility of the 
Markov chain approach can be seen in the use of projecting possible clinical pain 
presentations after combat injury. For this evaluation Markov chains modeled pain state 
transitions by both initial presentations of the true RAMBPOS sample as well as 




simulations were based on the assumption that all participants in a hypothetical combat-
injured population present with severe pain within the first month after injury. In these 
projections individuals in severe average pain or pain right now quickly transition to 
lower pain intensity states within 3 and 6 months after injury. However, there is 
probability that individuals, both those receiving RA and No RA, remain in chronic 
severe or moderate average pain up to two years after severe injury. This sustained 
absorption and steady proportion of individuals in the higher pain intensity states 
highlight the need for continued assessment and management of all combat-injured 
veterans.  
Acute pain trajectories have been used as predictors of the future development for 
chronic pain after acute tissue trauma, such as surgery. Others have examined the utility 
of linearly predicting acute pain, specifically following surgery, but are limited to a few 
days or months at a time and do not evaluate the long-term nature of chronic pain 
transitions.30-32 Similar to other analyses of pain trajectories, the findings of this study 
confirm the general improvement of pain intensity over time.30,31,33,34 However, 
improvements are not necessarily linear in nature as proposed in the past. Understanding 
pain trajectories with higher precision than what simple linear fits are able to provide, are 
needed.30 Markov models allow the characterization of individual’s pain trajectories 
through transition states and thereby able to identify abnormal acute pain resolutions. 
These unaddressed abnormal resolutions can present as stable prolonged time spent in 
moderate or severe chronic pain after 3 to 6 months. Tighe et al.’s probabilistic Markov 
chains demonstrate the utility of stratifying patients into risk groups for increased pain 




476,108), the author’s do not account for pain management interventions patients receive. 
Althaus et al. followed patients up to six months after surgery to project long-term 
transitions from acute to chronic pain, but again did not consider initial acute pain 
interventions. This analysis uniquely evaluated pain trajectories after combat injury 
stratified by RA status using a probabilistic approach. Additionally, this evaluation offers 
an overview of the longitudinal transitions of pain across multidimensional pain 
outcomes (e.g. worst pain, average pain, and pain right now), unlike other analyses that 
are limited to only acute post-operative pain trajectories and current pain intensity 
presentations.  
Longitudinal studies examining pain trajectories over weeks and months after early 
pain management are important in order to describe how pain changes as severe physical 
injuries resolve.35 This lack of literature may be due, in part, to the inherently 
unpredictable nature of trauma and the focus of controlling pain rather than preventing 
pain from occurring.36 Studies examining severely injured civilian populations have 
reported that pain can affect individuals up to 36 months after injury.37 Moreover, 
elevated pain intensity immediately after injury is strongly associated with chronic pain 
in civilian populations with lower extremity injures.35 The retrospective nature of much 
of this body of injury and pain trajectory research emphasizes the need for prospective 
studies. This probabilistic modeling provides a possible means by which to illustrate pain 
trajectories utilizing existing pain data sources from clinical trials, such as RAMBPOS, 
and health records.  
In this secondary analysis, RA and systemic pain management approaches were 




injury. While differences in probability transitions were found between RA groups, they 
did not reach statistical significance. RA distributions were not statistically different from 
No RA probability distributions. RA is an established multimodal pain management 
intervention demonstrated to improve acute pain, one of the largest risk factors for 
developing chronic pain, after combat injury in Iraq and Afghanistan.12,13,16,19 
Researchers have confirmed the improvements of RA over systemic analgesics on 
improving health outcomes after injury.38-40 Further, a meta-analysis of civilian surgical 
patients indicated that epidural anesthesia and blocks help prevent chronic postoperative 
pain up to one year after surgery.41 Studies examining the benefits of RA in combat 
injured populations beyond acute care are limited in availability; possibly due to the 
highly transient nature of military personnel and veterans after discharge as they return to 
their civilian lives. While there was no statistically significant difference in the 
probability distributions between RA and No RA, this analysis was the first to 
demonstrate the utility of using Markov chains to model pain transitions after combat 
injury in OEF/OIF military personnel and veterans. For example, transition matrices 
indicate the utility of RA in reducing the proportion of individuals in prolonged severe 
and moderate pain within a few months after combat injury up to two years later. This 
work estimates necessary underlying probability parameters to build future Markov 
models that incorporate utility values for quality of life, and even cost.  
Limitations of this analysis include the nature of the clinical data used and the 
assumptions needed to utilize Markov chains. Despite RAMBPOS being one of the 
largest and most comprehensive dataset of patient-reported pain outcomes after combat 




outcomes using Markov models.23 Given the limited number of observations, transition 
probabilities for the matrices were evenly populated from observations by RA and No 
RA cohorts. Future analyses should be conducted on more robust datasets of pain 
outcomes. Inherent limitations of the Markov chain include assumptions of independence 
that may defy the true nature of pain. For example, an individual’s pain intensity 
responses may be influenced by their previous pain intensity and therefore not 
independent to predict future pain intensity. Further, these Markov transitions evaluated 
differences by RA receipt, and did not consider underlying factors that can influence an 
individual’s pain intensity, such as mental health diagnoses. Approximately a quarter of 
the data utilized for this analysis were generated by individuals who joined RAMBPOS 
more than six months after injury. Therefore, it is important to note that those participants 
joining later have inherently less follow-up time than those enrolled earlier after injury 
and could have poorer pain outcomes on which average probability transitions were 
estimated. However, RAMBPOS is one of the first longitudinal studies measuring 
patient-reported pain outcomes after combat injury and evaluating acute pain 
management interventions. Therefore, this work is exploratory in nature and provides the 
parameters for future modeling work in the regards to conducting cost-effectiveness 
analyses with analgesic interventions. In the future, Bayesian approaches can be 
incorporated to calibrate model parameters and probabilistic distributions to overcome 






In conclusion, the unique features of the Markov model enable evaluation of pain 
intensity trajectories after combat injury. Moreover, this analysis captured the 
multidimensional nature of pain intensity, as opposed to a single 0 to 10 assessment of 
current pain intensity at time of observation. Findings indicate that individuals receiving 
RA transition quickly out of severe and moderate average pain intensity in the first six 
months after injury compared to No RA individuals, however, there was no statistically 
significant difference in the probability distributions. This research provides foundational 
findings that can be leveraged for future cost-effectiveness analyses, that in turn can 








Figure 4-1: Visualization of the Markov model’s pain states (circles) 





Table 4-1: RAMBPOS Subsample Characteristics  
  Total 
  N=355 
Age     
   Mean  28 
   Std. dev.  7.1 
Number of Deployments    -    
   Mean  2 
   Std. dev.  1.3 
Length of Stay in Hospital    -    
   Mean  36.7 
   Std. dev.  33.4 
Injury Severity Score    -    
   Mean  18.4 
   Std. dev.  10.8 
  % N 
ISS Category    -    
   Minor (£9)  21.20% 75 
   Moderate (10-15) 23.50% 83 
   Serious (16-24) 32.60% 116 
   Severe (³25) 22.70% 81 
Time Since Injury to Entering Study    -    
   ≤ 6 Months 75.80% 269 
   6 Months ≤ 1 Year 14.30% 51 
   > 1 Year  9.90% 35 
Regional Anesthesia     
  Yes 52.11% 185 
  No 47.89% 170 
Sex     
   Female  0.80% 3 
   Male  99.20% 352 
Race     
   White  77.60% 276 
   Black  5.30% 19 
   Other  17.10% 60 
Ethnicity    -    
   Hispanic  12.60% 44 
   Non-Hispanic  87.40% 311 
 





Table 4-2: RAMBPOS Participant Data for Markov Model 
Variables Observations  Percent (N=2214) 
Worst Pain (BPI Score)   
   None (0) 217 9.8% 
   Mild (1-4) 865 39.2% 
   Moderate (5-6) 467 21.1% 
   Severe (7-10) 665 30.0% 
Average Pain (BPI Score)   
   None (0) 437 19.8% 
   Mild (1-4) 1450 65.5% 
   Moderate (5-6) 270 12.2% 
   Severe (7-10) 57 2.6% 
Pain Right Now (BPI Score)   
   None (0) 796 35.9% 
   Mild (1-4) 1180 53.3% 
   Moderate (5-6) 184 8.3% 
   Severe (7-10) 54 2.4% 
Regional Anesthesia   
   Yes (n=185) 1150 51.9% 
   No  (n=170) 1064 48.1% 





Figure 4-2: Illustration of Expanded to Condensed Pain States  
Transition Matrix of Post-Injury Worst Pain, 11 States (BPI 0-10) [N=2214] 
 0 1 2 3 4 5 6 7 8 9 10 
0 0.65 0.15 0.07 0.05 0.03 0.01 0.01 0.01 0.01 0.00 0.01 
1 0.25 0.31 0.19 0.11 0.06 0.03 0.01 0.02 0.01 0.01 0.00 
2 0.09 0.16 0.23 0.17 0.16 0.05 0.06 0.04 0.02 0.01 0.01 
3 0.09 0.09 0.16 0.27 0.18 0.10 0.03 0.05 0.03 0.00 0.00 
4 0.05 0.03 0.10 0.25 0.20 0.12 0.12 0.08 0.04 0.01 0.00 
5 0.03 0.01 0.06 0.13 0.22 0.20 0.14 0.14 0.05 0.00 0.02 
6 0.02 0.02 0.04 0.07 0.15 0.15 0.20 0.17 0.14 0.03 0.01 
7 0.01 0.00 0.03 0.06 0.10 0.11 0.15 0.24 0.20 0.06 0.04 
8 0.00 0.01 0.03 0.04 0.05 0.10 0.11 0.21 0.30 0.10 0.05 
9 0.00 0.00 0.00 0.03 0.03 0.05 0.12 0.17 0.32 0.20 0.08 
10
 
0.02 0.00 0.05 0.02 0.04 0.04 0.14 0.21 0.21 0.11 0.16 
 
Transition Matrix of Post-Injury Worst Pain, 4 States (BPI 0-10) [N=2214] 
 No Pain  (0) 
Mild  
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Figure 4-3: Transition Matrices of Average Pain and Pain Right Now 
Transition Matrix of Post-Injury Average Pain, 4 States BPI (0-10) [N=2214] 







































0.00 0.17 0.75 0.08 
 
Transition Matrix of Post-Injury Pain Right Now, 4 States BPI (0-10) [N=2214] 
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Table 4-3: Initial Pain State Distributions from RAMBPOS (N=385) 
 Worst Pain Average Pain Pain Right Now 
 RA No RA RA No RA RA No RA 
No Pain 4.8% 9.4% 11.8% 12.9% 25.3% 12.9% 
Mild 28.0% 34.7% 68.8% 65.9% 56.5% 65.9% 
Moderate 31.7% 18.2% 14.5% 15.9% 12.9% 15.9% 








Figure 4-4: Transition Matrices of Worst Pain, by Regional Anesthesia 
Transition Matrix of Post-Injury Worst Pain, for RA, 4 States BPI (0-10) [N=1150] 
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0.01 0.06 0.42 0.52 
BPI = Brief Pain Inventory, RA= regional anesthesia  
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Figure 4-5: Projected Pain Transitions by Regional Anesthesia, Worst Pain 
 
RA= regional anesthesia 



















Projected Pain Transitions By, RA 
No Pain, RA Mild, RA Moderate, RA Severe, RA
No Pain Mild Moderate Severe
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Figure 4-6: Transition Matrices of Average Pain, by Regional Anesthesia 










































0.00 0.17 0.67 0.17 
Transition Matrix of Post-Injury Average Pain, for No RA, 4 States BPI (0-10) [N=1064] 







































0.00 0.17 0.83 0.00 
BPI = Brief Pain Inventory, RA= regional anesthesia  
The distributions were statistically equivalent by RA status both for average pain (AD = 0.238, P > 0.05) 
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Figure 4-7: Projected Pain Transitions by Regional Anesthesia, Average Pain 
  
RA= regional anesthesia 



















Projected Pain Transitions By, RA 
No Pain, RA Mild, RA Moderate, RA Severe, RA No Pain Mild Moderate Severe
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Figure 4-8: Transition Matrices of Pain Right Now, by Regional Anesthesia 
Transition Matrix of Post-Injury Pain Right Now, for RA, 4 States BPI (0-10) [N=1150] 








































0.09 0.26 0.48 0.17 
Transition Matrix of Post-Injury Pain Right Now, for No RA, 4 States BPI (0-10) [N=1064] 









































0.10 0.38 0.38 0.14 
BPI = Brief Pain Inventory, RA= regional anesthesia  
The distributions were statistically equivalent by RA status both for pain right now (AD = 0.1853, P >0.05) 
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Figure 4-9: Projected Pain Transitions by Regional Anesthesia, Pain Right Now 
 
RA= regional anesthesia 



















Projected Pain Transitions By, RA 
No Pain, RA Mild, RA Moderate, RA Severe, RA No Pain Mild Moderate Severe
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Figure 4-10: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Worst Pain 
 



















Projected Pain Transitions from Severe Pain by Regional Anestheshia, Worst Pain




Figure 4-11: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Average Pain 



















Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, 
Average Pain




Figure 4-12: Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Pain Right Now 



















Projected Pain Transitions Beginning from Severe Pain by Regional Anesthesia, Pain 
Right Now
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Below, !"is a general discrete time Markov chain with a transition matrix, #(%, '), for any 
state between %	*+,	'  
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In other words, the probability of moving from one state to another state, in one time 








Adequate pain management after combat-related injury is essential to ensure optimal 
physical and mental health recovery. While multimodal pain management using regional 
anesthesia (RA) was a vital component of the military’s pre-hospital and acute care pain 
management protocol for personnel injured in OEF/OIF conflicts, the long-term benefits 
of RA have not been well-researched in this population. Therefore, the overall goal of 
this dissertation was to use a biopsychosocial perspective to identify the complex and 
interrelatedness of pain and post-traumatic stress disorder (PTSD) symptom severity 
while also evaluating the short- and long-term associations of early pain management 
after combat related-injury on pain intensity and interference. Chapter 2 of this 
dissertation synthesized presentations of pain, PTSD, and depression after combat-related 
injury and highlighted that timely pain management, in addition to controlling acute pain, 
is associated with reduced mental health symptoms after polytrauma. Informed by the 
established relationship between pain and mental health symptom presentations in 
combat-injured military personnel and veteran populations, Chapter 3 evaluated the 
association of RA and PTSD symptom trajectories with pain intensity and interference in 
a sample of combat-injured OEF/OIF military personnel and veterans. Chapter 4 
examined pain trajectories after combat injury in a probabilistic manner, while stratifying 
by early RA receipt status.  
This dissertation contributes to the existing knowledge of providing adequate pain 
management for combat-injured military personnel and veterans while assessing the 




research. The ability to expand science in the use of early aggressive acute pain 
management with RA, and its impact on long-term pain outcomes will be invaluable for 
future trauma responders and clinicians managing acute pain to prevent the development 
of chronic pain and possible disability.  
Major Findings of Chapter 2 
There is a paucity of studies examining the interrelatedness of pain, PTSD, and 
depression associated with combat injury. This integrative review of twenty-two peer-
reviewed publications examined the complex relationship between pain, PTSD, and 
depression in combat-injured veterans and military personnel who served in OEF/OIF. 
Findings indicated that greater pain severity poses risks for developing PTSD following 
combat injury in this specific population. Moreover, early pain management may lessen 
the risk for developing PTSD. Following combat injury, depression can be a comorbidity 
of and a contributing risk factor to PTSD. The foundation of cross-sectional research 
examining pain, PTSD, and depression symptoms highlights the need for further analysis 
of these longitudinal relationships in combat-injured military personnel and veterans.  
The body of literature in this integrative review examining clinical presentations after 
combat injury demonstrated a compelling demand for improvements in the continuity of 
assessments of pain and mental health symptoms across transitions in care. There are 
limited longitudinal studies investigating the prolonged surveillance of symptoms after 
combat-related injury that is further hindered by limited use of standardized assessment 
tools. The cross-sectional nature, on which existing research is built upon, does not 
account for the time since initial injury or consider the utilization of repeated patient-




care. Future research efforts should include ongoing assessments with standardized 
measures in studies that investigate the relationship of pain and mental health beyond 
acute care and throughout recovery. 
Major Findings of Chapter 3 
This secondary analysis was one of the few longitudinal studies examining the 
association of early acute pain management, PTSD symptoms and pain outcomes after 
combat-related injury. Findings highlighted the positively correlated monotonic 
association between PTSD symptom severity and, pain intensity and interference up to 
twenty-one months after combat injury. Individuals receiving RA experienced lower pain 
intensity, even after controlling for injury severity and time from injury to observation 
using a mixed effect model. This association suggests that the delivery of analgesics and 
anesthetics using peripheral nerve blocks or epidurals improve short- and long-term pain 
intensity and interference after combat injury. Moreover, PTSD symptom trajectories, 
specifically military personnel and veterans with worsening PTSD, are associated with 
small statistically significant increases in average pain intensity and pain right now. This 
emphasizes the value of RA in the immediate after math of injury and throughout 
recovery.  There is a need for continued evaluation of pain-related outcomes and 
comprehensive mental health treatment approaches beyond one year after injury. The 
association between pain and PTSD symptom trajectories, following combat injury, can 





Major Findings of Chapter 4 
In order to effectively manage acute pain intensity after injury, timely and targeted pain 
management is essential; however, less is known regarding how pain management 
interventions influence future post-injury pain trajectories. Efforts to evaluate pain 
trajectories after combat injuries are further impeded by missing data and possibly that 
personnel are lost to follow up as they transition out of their active duty military roles and 
back into their communities. A Markov chain approach was used to generate probabilistic 
transition matrices of pain trajectories after combat injury across multiple dimensions of 
pain intensity. The rationale for this using approach includes the capability of Markov 
models to explicitly account for the timing of events and state transitions, whereas time is 
often less explicitly accounted for in standard decision trees and clinical trials. This 
allows for modeling beyond the duration of the study data collection period. Findings 
from this secondary analysis showed that both RA and systemic pain management 
approaches were effective in reducing length of time spent in severe and moderate pain 
intensity after injury. There were more pronounced changes in the first six months after 
injury with individuals expected to have higher probabilities to move from states of high 
pain intensity, encompassing severe and moderate pain, to stabilize in states of mild or no 
pain, compared to beyond six months. This work provides the necessary underlying 
probabilistic parameters on which to build future simulated Markov models that 






It is important to note several limitations of this dissertation. The study’s secondary 
nature hinders the ability to demonstrate causation of RA to improve pain intensity or 
interference. It does however, afford an important opportunity to examine the 
associations between early pain management approaches, PTSD symptom trajectories, 
and pain outcomes. The RAMBPOS dataset is the only longitudinal investigation of 
comprehensive patient-reported outcomes from the time of acute care and up to two years 
after combat injury. Therefore, this observational approach is a rare opportunity to 
evaluate how RA administration is associated with changes in pain intensity. This 
research did not examine the specific symptom criteria of PTSD, but instead examined 
total symptom severity and, uniquely, PTSD trajectories after combat injury. Changes to 
diagnostic criteria for PTSD assessment tools, such as the PCL-M, since the RAMBPOS 
data collection period makes it impossible to evaluate new diagnostic criteria (i.e. 
alterations in cognitive states and mood). Despite this challenge, the PCL is widely used 
in the literature and updated DSM-5 PCL instruments perform similarly in accurately 
capturing the prevalence of PTSD in OEF/OIF veterans.1 The RAMBPOS was 
exclusively comprised of OEF/OIF military personnel and veterans, however findings of 
this research can inform the acute pain management care needs of civilian polytrauma 
cohorts. The symptom trajectories of civilian survivors of trauma and the effects of acute 
pain management interventions have not been extensively studied beyond acute care 
discharge. Civilian trauma care can be more comprehensive, in a way that accounts for 
the longitudinal trajectory of pain and mental health symptoms from the time of injury 




care with long-term optimal recovery in mind will depend on leveraging findings from 
pre-existing datasets of patient-reported outcomes from injured military personnel and 
veterans. Moreover, the ability to expand science in the use of early aggressive acute pain 
management with RA, and its impact on long-term pain outcomes can be invaluable for 
future trauma responders and clinicians in civilian settings.  
Implications 
Implications of this research include the continuation of leveraging research of military 
advancements for trauma related pain to meet the pain management needs of severely 
injured civilians. The measures taken to ensure preservation of life after complex injuries 
require innovations of care commensurate with the extensiveness of bodily harm. 
Therefore, advancements made in trauma care are inextricably linked to war.2  This 
includes the many modern clinical interventions used in civilian trauma care, which 
originated from the military. These trauma care improvements include the use of 
tourniquets to reduce mortality from hemorrhage, effective antimicrobial use for wound 
care to prevent infection, and helicopters for rapid transport after trauma in civilian health 
systems.2,3  The use of these care advancements and other technical developments (e.g. 
protective body armor) have enabled trauma providers to preserve life after devastating 
injuries. In spite of the severity of injuries, case fatality rates among American military 
personnel are half those seen in previous armed conflicts (7.1%, OEF/OIF; 15.8%, 
Vietnam War).4,5 The improved survival of critically ill trauma patients necessitated 
greater attention be paid to pain management from the point of combat injury and beyond 
throughout OEF/OIF. The delivery of multimodal anesthesia and analgesia via peripheral 




adequate and safe uninterrupted pain management after polytrauma and reducing future 
chronic pain intensity, as seen in this dissertation.  
Other trauma care advancements, including RA for continuous optimal multimodal 
pain management, have had less penetration into the civilian sector. The use of 
indwelling nerve catheters has transformed pain control for combat-related extremity 
injuries since the Vietnam War.6 Up to 57% of OEF/OIF military personnel with combat-
related extremity injuries receive pain management in the acute care period via RA.6,7  
Unfortunately, RA techniques have not been widely incorporated within civilian 
emergent care settings.8  In the 2016 report titled, A National Trauma Care System: 
Integrating Military and Civilian Trauma Systems to Achieve Zero Preventable Deaths 
After Injury,8 the National Academy of Medicine identified: 
“Lessons learned by U.S. military personnel that improve the care and recovery of 
service members injured on the battlefield have been neither thoroughly nor 
adequately disseminated throughout the military, nor have they been translated 
reliably into civilian trauma care. The result has been many thousands of instances of 
preventable death and needless disability across the two sectors, along with 
excessive costs”9  
 
The demonstrated success of RA for pain management in the combat theater, in transport, 
and throughout surgical and acute care cannot be neglected in the interwar period.10-12 
The ability to expand science in the use of early aggressive acute pain management with 
RA, and its impact on long-term health outcomes, will be invaluable for future trauma 
responders and clinicians managing acute pain to prevent the development of pain, pain 
interference and associated disability after serious injury. Civilian care and military 
personnel and veteran trauma care do not exist in silos. 
Now more than ever, it is necessary to translate military trauma pain care into the 




injuries akin to those of battlefield trauma. The increasing incidence of domestic mass 
casualty incidents, including the horrific events at the Boston Marathon (Massachusetts, 
2013), Orlando Night Club (Florida, 2016), Las Vegas (Nevada, 2017), and Marjory 
Stoneman Douglas High School (Florida, 2018), calls for urgency in adopting military 
casualty pain care. Despite the surge in lethality of these recent attacks, it is important to 
recognize that there are many more survivors. These survivors can possibly suffer from 
devastating and debilitating injuries that would benefit from early aggressive pain 
management in similar ways to military combat pain care. For example, retrospective 
profiles of wound patterns in civilian public mass shooting incidences identified that as 
much as 20% of victims sustain extremity injuries.13 Pain has been found to effect up to 
50% of severely injured civilians nearly three years after acute trauma care.14  
Additionally, as much as 23% to 28% of injured civilians requiring trauma care develop 
PTSD within one year of injury.14,15 The frequency of these events and severity of 
injuries sustained by survivors require trauma providers be able to provide timely pain 
management interventions.  
The frequent co-occurrence of pain and PTSD after injury elicits a need for dual 
management of conditions throughout injury related care, beginning in pre-hospital and 
acute care. Uncontrolled pain and increased pain after injury is associated with an 
increased risk for developing PTSD.16-18  Further, immediate pain management in 
combat-injured military populations is associated with reduced risk of developing PTSD 
after injury.19  Clinical presentations of pain and PTSD after injury, coupled with the 
continued necessity of administering optimal analgesic medication in acute trauma care 




control. Additional research is needed investigating how pain trajectories can influence 
future mental health symptom severity. This dissertation found that the application of RA 
and systemic pain management approaches reduce the amount of time spent experiencing 
high pain intensity and reduce long-term pain intensity after experiencing severe injuries. 
It is imperative that clinicians and researchers continue the translation, implementation, 
and evaluation of RA in civilian trauma settings.  
Future Directions 
Advancing the use of RA in civilian trauma care settings will require continued 
longitudinal research of severely injured persons and expanded opportunities for 
anesthesia and pain management providers to be trained in RA techniques. Future 
research in this line of inquiry must recognize the importance of the relationship between 
physical symptoms and psychological symptoms, as framed by the Biopsychosocial 
Model for Chronic Pain, after injury. Therefore, assessment of pain and mental health 
symptoms that extends beyond acute trauma care is essential to expand current 
knowledge of how findings from this research relate to civilian populations. Additionally, 
further prospective research examining the effects of RA on PTSD symptom severity, 
specifically if there is an association with a reduction in symptoms. These future 
investigations will require that patient-centered trauma care combine immediate survival 
treatment with consideration of long-term needs of pain management and mental health 
support. Doing so will depend on injured civilians having access to effective pain 
management approaches, such as RA. This requires coordinated efforts within health 




Findings from this research may have the ability to advance the science to 
promote the science behind the care of certified registered nurse anesthetist (CRNA) led 
RA treatments for all traumatically injured persons. CRNAs are well positioned in many 
acute trauma care settings and can leverage their clinical training to incorporate effective 
pain management across the continuum of care for injured persons.20  However, the 
proportion of time spent in of training for anesthesia providers to practice administering 
RA has not expanded since 199021 even as the number of patients requiring care for 
severe injuries has increased and as have the  total associated costs in the United States 
(U.S.).22 In light of this growing proportion of injury survivors and swelling costs of both 
pain and trauma in the U.S., there is a compelling need to determine the clinical and cost-
effectiveness of RA after injury.22,23 Future work evaluating the cost-effectiveness of RA 
over systemic analgesia after injury is necessary to advancing trauma care. 
Demonstrating the effectiveness of CRNA led RA administration has the potential to 
support policies expanding training opportunities and scope of practice for CRNAs in 
order to optimize pain management for injured persons.  
Conclusion 
In conclusion, this dissertation contributes to current understandings in the short- and 
long-term care requirements of combat-injured military personnel and veterans serving in 
OEF/OIF. There is a complex relationship between pain and mental health symptoms, 
specifically, PTSD, after serious combat injury. There is a significant positive 
relationship between patient-reported pain outcomes, both pain intensity and interference, 
and total PTSD symptom severity up to twenty-one months after combat injury. 




average pain and pain right now after combat injury compared to individuals with 
improving PTSD trajectories. Individuals receiving RA experience less intense pain after 
injury than individuals not receiving RA. Markov modeling projected pain trajectories 
individuals may experience after combat-related injuries. Moreover, when stratified by 
receipt of RA and systemic pain management approaches there is a pronounced 
movement from high pain intensity to low pain intensity in the first six months after 
injury. This dissertation highlights the importance of sustaining efforts to monitor and 
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